Zheng et al . Journal of Hematology & Oncology ( 2023 ) 16 : 123 https : / / doi . org / 10 . 1186 / s13045 - 023 - 01522 - 5 REVIEW Open Access © The Author ( s ) 2023 . Open Access This article is licensed under a Creative Commons Attribution 4 . 0 International License , which permits use , sharing , adaptation , distribution and reproduction in any medium or format , as long as you give appropriate credit to the original author ( s ) and the source , provide a link to the Creative Commons licence , and indicate if changes were made . The images or other third party material in this article are included in the article’s Creative Commons licence , unless indicated otherwise in a credit line to the material . If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use , you will need to obtain permission directly from the copyright holder . To view a copy of this licence , visit http : / / creativecommons . org / licenses / by / 4 . 0 / . The Creative Commons Public Domain Dedication waiver ( http : / / creativecom‑ mons . org / publicdomain / zero / 1 . 0 / ) applies to the data made available in this article , unless otherwise stated in a credit line to the data . Journal of Hematology & Oncology Phase separations in oncogenesis , tumor progressions and metastasis : a glance from hallmarks of cancer Le‑Wei Zheng 1 , Cui‑Cui Liu 1 and Ke‑Da Yu 1 * Abstract Liquid – liquid phase separation ( LLPS ) is a novel principle for interpreting precise spatiotemporal coordination in living cells through biomolecular condensate ( BMC ) formation via dynamic aggregation . LLPS changes individual mol‑ ecules into membrane‑free , droplet‑like BMCs with specific functions , which coordinate various cellular activities . The formation and regulation of LLPS are closely associated with oncogenesis , tumor progressions and metastasis , the specific roles and mechanisms of LLPS in tumors still need to be further investigated at present . In this review , we comprehensively summarize the conditions of LLPS and identify mechanisms involved in abnormal LLPS in cancer processes , including tumor growth , metastasis , and angiogenesis from the perspective of cancer hallmarks . We have also reviewed the clinical applications of LLPS in oncologic areas . This systematic summary of dysregulated LLPS from the different dimensions of cancer hallmarks will build a bridge for determining its specific functions to further guide basic research , finding strategies to intervene in LLPS , and developing relevant therapeutic approaches . Keywords Biomolecular condensate , Membrane‑less organelle , Cancer , Novel therapeutics , Liquid – liquid phase separation Background The spatial and temporal coordination of biochemi - cal reactions is crucial for cellular physiology [ 1 ] . While membrane - bound organelles are essential for spatially organized cellular processes , the discovery of membrane - less organelles ( MLOs ) has shed light on new mecha - nisms for tightly controlling processes within cells [ 2 ] . MLOs , as known as biomolecular condensates ( BMCs ) , include the nucleolus [ 2 ] , Cajal bodies [ 3 ] , nucleoli [ 4 ] , stress granules ( SGs ) [ 5 – 7 ] , and super - enhancers ( SEs ) [ 8 – 10 ] etc . These structures typically range from 0 . 1 to 3 µm [ 11 ] and play key roles in facilitating or modulat - ing specific cellular processes . BMCs and MLOs are both formed by the process of phase separation , and in most scenarios , these two concepts are equivalent . Until the emergence of the concept of liquid – liquid phase separation ( LLPS ) , the formation and organiza - tion of MLOs remained unclear [ 12 ] . Thus , LLPS pro - vides a reasonable framework to explain the formation mechanism of MLOs and BMCs . This dynamic process involves the transition of biomolecules from a homoge - neous environment to sparse and dense phases [ 11 , 13 , 14 ] , aiming to reach the lowest - entropy state . Notably , LLPS occurs when multivalent biopolymers instantane - ously interact with each other [ 15 – 17 ] , forming liquid - like entities such as bodies , puncta , granules , droplets , and condensates [ 18 ] . * Correspondence : Ke‑Da Yu yukeda @ fudan . edu . cn 1 Department of Breast Surgery , Department of Oncology , Key Laboratory of Breast Cancer in Shanghai , Cancer Institute , Fudan University Shanghai Cancer Center , Shanghai Medical College , Fudan University , Shanghai 200032 , China Page 2 of 23 Zheng et al . Journal of Hematology & Oncology ( 2023 ) 16 : 123 Normal BMCs ensure basic cellular functions , whereas their aberrant forms result in cellular dysfunction and possible tumorigenesis . Studies have demonstrated that LLPS are crucial in the regulation of tumor onset , pro - gression [ 19 ] , including promoting cancer cells pro - liferations and metastasis . Further , the hallmarks and enabling characteristics of cancer in the 2022 version provide a framework for further oncological studies [ 20 ] . However , understanding of the regarding phase separa - tion processes involved in each hallmark is still limited . Therefore , unveiling a novel dimension of its biological functions is in need . In this review , we include all cutting - edge and typi - cal articles related to liquid – liquid separation in oncol - ogy . Firstly , we describe the methods used to investigate LLPS , followed by their role in promoting the formation of BMCs / MLOs . Subsequently , we examine the current understanding of how LLPS influences tumorigenesis , progression and their emerging role in cancer treatment . Finally , we comprehensively summarize the latest insights into methods to interfere with aberrant forms of BMCs . Mechanisms and methods associated with the phenomenon of LLPS Concepts and mechanisms Phase separation is defined as the spontaneous aggrega - tion of molecules when their concentration exceeds a certain threshold , thus forming a membrane - less com - partment [ 21 ] . Typically , the interactions between mac - romolecules in LLPS are typically non - covalent and of low affinity [ 22 , 23 ] . This process is often driven by the modification of intrinsically disordered regions ( IDRs ) within proteins [ 24 , 25 ] . The concept of LLPS was first introduced in the biochemical field of biochemistry in 2009 by Hyman and colleagues with various milestone events followed subsequently ( Fig . 1 ) , offering a novel perspective on various MLOs distributed in cells ( Fig . 2 ) [ 26 ] . Although several in silico tools help forecast the potential of phase - separated molecules ( Table 1 ) , com - prehensive summaries of the characteristics and condi - tions that induce LLPS are limited . Structural characteristics and critical components that triggers LLPS The concept of a driver ( or scaffold ) / client is widely accepted . Proteins , DNA , and RNA can also be used as scaffolds . With multiple binding sites , these macromol - ecules facilitate weak interactions and trigger LLPS . The detailed structures are summarized below . Multi‑foldable domains One of the most common structural features that facili - tates LLPS is multivalency , which involves the interac - tion of various macromolecules ( Figs . 3A – C ) . By using Fig . 1 History of LLPS research developments . Milestone discoveries are outlined Page 3 of 23 Zheng et al . Journal of Hematology & Oncology ( 2023 ) 16 : 123 multiple , similar domains to mediate the interactions , these macromolecules effectively trigger LLPS and attract client molecules to form condensates . For exam - ple , the proline - rich motif ( PRM ) domain characteris - tic of the neural Wiskott - Aldrich syndrome ( N - WASP ) interacts with the SH3 domain of NCK , thereby induc - ing LLPS [ 53 ] . A similar principle applies to the nephrin / Nck / N - WASP system , wherein the phosphotyrosines of nephrin interact with the SH2 and SH3 domains of NCK to bind to the PRMs ( Fig . 3D ) [ 54 ] . Similarly , higher - order polymerized structures are formed via the tan - dem dimerization domains of the speckled POZ protein ( SPOP ) and its interaction with cullin - 3 - RING ubiquitin ligase and other substrates , promoting its localization in nuclear speckles [ 55 ] ( Fig . 3E ) . Dimerization or oli - gomerization of proteins can also contribute to LLPS . For example , when the dimerization of HP1a is disrupted , the mobility of the droplets increases , hindering the matura - tion of heterochromatin formations ( Fig . 3F ) [ 56 ] . IDR / low‑complexity domains contribute to LLPS IDRs are distinctive features of certain proteins of the condensates , accounting for 33 – 55 % of eukaryotic pro - teomes [ 57 , 58 ] . Like IDRs , low - complexity domains ( LCDs ) are also distinctive features of proteins comprised by highly biased amino acid compositions [ 59 ] . IDRs and LCDs lack stable tertiary structures and have flex - ible conformations , making them prone to undergo LLPS [ 11 , 60 – 62 ] . β sheets in TDP34 / FUS ( Fig . 3G ) , coiled - coil domains in YAP / TAZ ( Fig . 3H ) and alpha - helix in TDP43 ( Fig . 3I ) , exemplify the role of LCDs in LLPS [ 63 – 69 ] . While IDR interactions involve pi - pi interactions , salt Fig . 2 Intra‑cellular MLOs within a eukaryotic cell . MLOs are distributed in the nucleus , nuclear membrane , cytoplasm , and plasma membranes of cells . Nucleolus , perinucleolar compartments , paraspeckles , Cajal bodies , transcription condensates , Gems , DNA repair foci , nuclear stress bodies , PcG bodies , histone locusbody , PML bodies , DNA replication bodies , polycombs , SPOP / DAXX bodies , super enhancers , heterochromatin , and amyloid bodies ( located in nucleolus ) are located in the nuclear by the LLPS . Whereas some MLOs are distributed in the nuclear membrane ( Babliani bodies ) , cytoplasm ( such as sec bodies , cGAS‑DNA condensates , ER associated TIS granules , autophagosome cargo condensates , stress granule , P granules , U bodies , Virus factories , Numb / pon complex , RNA transport granules , centrosome , inclusion bodies , siganling puncta , GW bodies , germ granules , transport RNP , and proteosome bodies , metabolic granules , keratin granules ) , and cell plasma membrane ( such as immune synapse densities , Numb / pon complex , Nephrin adhesion complexes / signaling clusters , T cell microclusters , and ZO mediated tight junction ) Page 4 of 23 Zheng et al . Journal of Hematology & Oncology ( 2023 ) 16 : 123 Table 1 Overview of databases related to liquid – liquid phase separation ( LLPS ) Category Database Availability Details of databases References Prediction of LLPS related proteins SGnn http : / / sgnn . ppmcl ab . com Proteins bearing prion‑like domains ( PrLDs ) [ 27 ] PhaSepDB http : / / db . phasep . pro / Phase‑separation related proteins [ 28 ] D 2 P 2 https : / / d2p2 . pro / search Phase‑separation related proteins [ 29 ] PLAAC http : / / plaac . wi . mit . edu / Prion‑Like Amino Acid Composition [ 30 ] DrLLPS http : / / llps . biocu ckoo . cn / Proteins in this database are classified as drivers , regulators and potential Clients [ 31 ] PhaSePro https : / / phase pro . elte . hu A manually curated database of LLPS driver proteins in various organisms , with emphasis on the biophysical prop‑ erties that govern phase separation . [ 32 ] BioGRID https : / / thebi ogrid . org / Database of Protein , Genetic and Chemical Interactions [ 33 ] LLPSDB http : / / bioco mp . ucas . ac . cn / llpsdb / home . aspx A database of proteins undergoing LLPS in vitro [ 34 ] HUMAN CELL MAP https : / / cell‑ map . org / or https : / / human cellm ap . org / Summarizes for each compartment the enrichment of expected domains and motifs as well as GO‑terms Provides channels to analyze spati‑ otemporal correlations between pro‑ teins in different organelles [ 35 ] MLOsMetaDB http : / / mlos . leloir . org . ar / Unified resource of MLOs and LLPS associated proteins [ 36 ] catGRANULE http : / / s . tarta glial ab . com / A website good at predicting LLPS pro‑ pensity of dosage‑sensitive proteins [ 37 ] PScore https : / / github . com / haoca i1992 / PScore‑ online # pscore‑ online A machine learning algorithm that pre‑ dicts the likelihood of phase separated proteins [ 38 ] Prediction of LLPS related RNAs RPS http : / / rps . renlab . org / # / Home A comprehensive database of RNAs involved in liquid – liquid phase separa‑ tion [ 39 ] RNAPhaSep http : / / www . rnaph asep . cn / # / Home A resource of RNAs undergoing phase separation [ 40 ] RNA granule data‑ base http : / / rnagr anule db . lunen feld . ca / A database containing RNA granules [ 41 ] Integreation of LLPS related diseases DisPhaseDB http : / / disph asedb . leloir . org . ar An integrative database of diseases related variations in liquid – liquid phase separation proteins [ 42 ] Prediction of specific structures or features of LLPS IUPred2A https : / / iupre d2a . elte . hu / Combination of the iupred database and the ANCHOR database , which can predict the disordered and disordered binding regions of proteins [ 43 ] PONDR http : / / www . pondr . com Predictor of natural disordered regions [ 44 ] MobiDB https : / / mobidb . org Provides information about intrinsically disordered regions and related features [ 45 ] CIDER http : / / pappu lab . wustl . edu / CIDER / Calculation of many different parame‑ ters associated with disordered protein sequences [ 46 ] ZipperDB https : / / servi ces . mbi . ucla . edu / zippe rdb / Predictions of fibril‑forming segments within protein [ 47 ] Metadisorder http : / / iimcb . genes ilico . pl / metad isord er / Prediction of protein disorder [ 48 ] DisMeta https : / / monte lione lab . chem . rpi . edu / disme ta / Prediction of protein disorder [ 49 ] Page 5 of 23 Zheng et al . Journal of Hematology & Oncology ( 2023 ) 16 : 123 Table 1 ( continued ) Category Database Availability Details of databases References Expasy https : / / web . expasy . org / compu te _ pi / Computation of the theoretical pI ( isoelectric point ) and Mw ( molecular weight ) [ 50 ] AMYCO http : / / bioinf . uab . es / amyco v04 / Evaluation of mutation impact on prion‑like proteins aggregation propensity [ 51 ] MFDp2 http : / / biomi ne . ece . ualbe rta . ca / MFDp2 / Accurate sequence‑based prediction of protein disorder which also outputs well‑described sequence‑derived infor‑ mation that allows profiling the pre‑ dicted disorder [ 52 ] Fig . 3 Basic condensates promoting features . A ‑ C Interactions between macromolecules that facilitate phase separation . D The SH2 domain of NCK binds to Nephrin , and NCK possesses three SH3 domains that can bind the proline‑rich motifs ( PRMs ) of N‑WASP , showing a typical repetitive molecular domain ( RMD ) that contributes to LLPS . E Oligomerization of SPOP and its interactions with substrates can induce phase separation . F Dimerization of HP1a promotes LLPS . G – I Several classic IDRs , which consist of LCDs . J – N Fundamental interacting force between IDRs . O Formation of BMCs , from dissociation to assembly . P – S Four types of sequence variations that drive phase separation Page 6 of 23 Zheng et al . Journal of Hematology & Oncology ( 2023 ) 16 : 123 bridges between opposing charge residues , pi - cation interactions , dipole - dipole interactions ( Van der Waals forces ) , and hydrophobic forces ( Figs . 3J – N ) represent different forms of LLPS [ 70 ] . Nucleic acids regulate LLPS Nucleic acids , especially the single - stranded nucleic acids , tend to aggregate to form droplets , whereas dou - ble - stranded nucleic acids tend to form gel - like aggre - gates [ 71 ] . Via electrostatic interactions and the pairing of repeating molecules , certain RNAs achieve polyvalency , effectively inducing LLPS in combination with proteins , as observed in the RG / RGG - rich domains of the SERPINE1 mRNA - binding protein 1 ( SERBP1 ) system [ 72 ] . In con - trast , the RNA concentration does not show a strong posi - tive correlation with the phase transition ability [ 73 ] . RNA modifications and non - coding RNAs can also induce LLPS spontaneously [ 74 ] or by attaching to proteins , facilitating clients recruitment for the condensate assembly [ 75 – 77 ] . Head‑to‑tail polymerization Occasionally , stable structural domains in proteins , such as SAM and DIX , retain their ability to trigger local condensation [ 78 , 79 ] . Among the dishevelled and axin components of the Wnt signaling , the DIX domain can assemble in a head - to - tail manner and promote Wnt signaling [ 80 , 81 ] . The SAM domain of the tankyrase protein forms similar puncta in a head - to - tail manner to bind and ribosylate poly ADP AXIN , thus promoting Wnt signaling [ 82 ] . These structural conditions facilitate the formation of condensates ( Fig . 3O ) . Sequence variations at the gene levels Disease - related genomic changes regulate LLPS . The NUP98 fusion protein in leukemia , carrying IDRs , serves as a good model for gene fusion [ 83 ] ( Fig . 3P ) . Similar results have been obtained with anaplastic lymphoma kinase ( ALK ) and BCR - ABL1 fusions [ 84 , 85 ] . Linear motifs that modulate ligand recognition within IDRs control the func - tion of alternatively spliced ( AS ) proteins [ 86 , 87 ] and mod - ulate their assemblies ( Fig . 3Q ) . On the contrary , repetitive motifs can induce pathogenic repeat expansions ( Fig . 3R ) . Missense mutations in IDRs and polymerization / modular domains may influence the phase transition status bilater - ally ( Fig . 3S ) . For instance , F291S and Y283S mutations in the heterogeneous nuclear ribonucleoprotein A2 scarcely affect the aggregation , whereas D290V and P298L muta - tions improve the condensation [ 88 ] . External conditions and physicochemical properties affect LLPS In this section , we focus on the conditions and the post - translational modifications ( PTMs ) which play a crucial role in regulating the dynamic transitions of molecules within the cell . The interplay of various intracellular conditions , such as the concentration of proteins , pH level , and changes of the cellular milieu , alter the strength of polyvalent interactions . These conditions are key regulators of tran - sitions within the cell . Furthermore , the concentrations of macromolecules are critical . When the concentration exceeds a critical threshold , the interaction between these macromolecules outweighs the forces that main - tain homogeneity of the system , making the solution susceptible to phase separation . Conversely , when the concentrations are below this threshold , the compo - nents remain evenly distributed [ 89 , 90 ] . The alterations of pH value can significantly impact LLPS by chang - ing the surface charges of amino acids , the α - carbonyl groups , and the α - amino terminal protonation status . pH alterations affect the stability of specific proteins and change the secondary structure from ordered to disor - dered . Altering the protonation of amino acids directly influences the chemical properties of macromolecules , further altering their intermolecular interactions and triggering LLPS . For example , the decreased cytoplas - mic pH , induced by external stimuli , can promote LLPS of naturally disordered proteins , as observed with Sup35 in yeast cells [ 91 ] . The increase in salt concentration and the addition of substances such as PEG3000 and glyc - erol can also modulate LLPS [ 73 , 92 ] . Additionally , weak electrostatic interactions , driven by IDRs , are highly sensitive to changes in pH and ionic strength , poten - tially explaining LLPS induction due to environmental changes [ 17 , 93 ] . In addition , temperature and stress levels can also trigger or disrupt LLPS by affecting the solubility of macromolecules [ 11 ] . Moreover , prion - like domains in proteins can sense pressure , influencing the solubility and phase behavior [ 94 , 95 ] . The PTMs are crucial in the regulation of phase transi - tions by altering molecular interactions or directly modi - fying the potency of BMCs [ 96 – 98 ] . PTMs can induce changes of biomolecules in the spatial structures and state of proteins [ 96 , 99 ] . PTMs of RNA - binding proteins ( RBPs ) can directly weaken or enhance the interactions between components , contributing to the formation of RNP granules , serving as an example of an MLO that is composed of RBP and RNA [ 96 ] . PTMs can promote or inhibit polyvalent interactions by influencing the condi - tion of proteins , thus affecting the occurrence of LLPS [ 100 ] . Notably , the Lys residues within the IDRs are par - ticularly prone to get SUMOylation , a modification that significantly contributes to the formation of the promye - locytic leukemia nuclear bodies ( NBs ) . De - SUMOylation can lead to the release of a constituent protein and the separation of NBs during mitosis [ 101 , 102 ] . Page 7 of 23 Zheng et al . Journal of Hematology & Oncology ( 2023 ) 16 : 123 Given the complexity of physicochemical conditions , the manipulation of PTMs is an intriguing approach to influence LLPS . Thus , it is pivotal to understand the pos - sible mechanisms in cancer - related PTMs associated with LLPS ( Table 2 ) . Deregulated phase separation in cancer Emerging evidence has robustly revealed that aber - rant BMCs are involved in various biochemical pro - cesses in human diseases and various oncogenic Table 2 Summary of cancer‑related PTMs involved in LLPS PTM Disease association Participants Biological role Regulation of LLPS References Ubiquitination Non‑small‑cell lung cancer USP42 Drives nuclear speckle mrna splicing and promote tumori‑ genesis Promotion [ 8 ] Multiple cancer types p62 Promotes tumor cell survival by upregulating p62 liquid droplet formation and degra‑ dation Promotion [ 103 ] Multiple cancer types SPOP / DAXX Co‑localizes with DAXX in Liquid Nuclear Organelles and facilitates DAXX Ubiquit‑ ination Promotion [ 104 ] Phosphorylation Multiple cancer types TAZ Formation of transcription compartment to promote gene expression Promotion [ 68 ] Methylation Leukaemia YTHDC1‑m6A condensates Facilitates a phase‑separated nuclear body and suppresses myeloid leukemica differentia‑ tion Promotion [ 105 ] Multiple cancer types UTX ( namely KDM6A ) Involved in chromatin‑ regulatory activity in tumour suppression Promotion [ 106 ] Sumoylation Colon cancer RNF168 Genomic instability and DNA damage repair Promotion [ 107 ] Acetylation Multiple cancer types KAT8‑IRF1 KAT8‑IRF1 condensate forma‑ tion boosts PD‑L1 transcription Promotion [ 108 ] Neddylation Acute promyelocytic leukemia ( APL ) PML / RARa Induce abberent LLPS and dis‑ rupt function of PML nuclear bodies to drive APL Inhibition [ 109 ] Table 3 Oncogenic signaling assosciated condensates that were involved in LLPS Signaling Pathway Cancer type Biomolecule / condensate Biological role Ref EGFR / RAS signaling Lung cancer EGFR condensates Regulating pro‑tumor activation of Ras [ 110 , 111 ] KRAS signaling Lung cancer EML4‑ALK condensates Modulating the KRAS signaling pathway , amplifying the oncogenic potential of this cascade , ultimately leading to dysregu‑ lated cellular proliferation and survival [ 112 , 113 ] JAK‑STAT3 signaling Lung cancer EZH2 / STAT3 Myristoylation modification of EZH2 enables its phase separation , com‑ partmentalize STAT3 within the con‑ densates and leads to the sustained activation and enhanced transcrip‑ tional activity of STAT3 [ 113 ] PI3K‑AKT‑mTOR signaling pathway Lung cancer stress granule dynamically interacting with a key component of lung oncogenic pathway , mTOR and its regulators , influencing its localization , activity , and downstream signaling [ 114 ] Page 8 of 23 Zheng et al . Journal of Hematology & Oncology ( 2023 ) 16 : 123 Table 3 ( continued ) Signaling Pathway Cancer type Biomolecule / condensate Biological role Ref Hippo signaling pathway Pan‑cancer YAP , TAZ , TEAD Undergoing LLPS , accumulat‑ ing in the nucleus coregulator with increased activity in various cancers [ 68 , 115 ] Hepatocellular carcinoma G6PC ( glycogen compartments ) YAP signaling activation [ 116 ] Hepatocellular carcinoma YAP / TEAD transcriptional conden‑ sates Acting as signaling hubs for the tumor microenvironment [ 117 ] Hepatocellular carcinoma Laforin‑Mst1 / 2 condensates Increasing hepatocarcinogenesis [ 116 ] p53 signaling Pan‑cancer p53 , 53BP1 53BP1 can form phase separa‑ tion droplets , which enrich tumor suppressor protein p53 . Cancer‑ associated mutation of p53 can accelerate the protein aggregation and amyloid formation by destroy‑ ing the folding of p53 core domain [ 118 , 119 ] Wnt / β‑catenin signaling Breast and prostate cancer DACT1 WNT signaling inhibition [ 120 ] TGF‑β signaling Colorectal cancer SMAD3 forming nuclear foci when the sign‑ aling pathway is activated [ 121 ] cAMP / PKA signaling Atypical liver cancer fibrolamellar carcinoma DnaJB1‑PKAcat fusion Tumorigenic cAMP signaling [ 122 ] Hepatocellular carcinoma RIα condensates Promoting cell proliferation and transformation [ 122 ] RAS signaling Pan‑cancer EML4‑ALK fusion RAS signaling overactivation [ 123 , 124 ] Pan‑cancer CCDC6‑RET fusion RAS signaling overactivation [ 123 , 124 ] Pan‑cancer LAT , GRB2 , SOS Activating Ras in tumour develop‑ ment [ 125 ] MAPK signaling RTK‑driven human cancer SHP2 Stimulation of downstream MAPK signaling pathways and ERK1 / 2 activation [ 126 ] Wnt / β‑Catenin signaling Colorectal cancer Destruction complex Regulating development and stemness [ 127 ] NRF2 / NF‑κB signaling Lung cancer p62 bodies Accelerating cancer development [ 128 ] NF‑κB pathway signaling Virus‑associated cancer p65 / inclusion body The trapped p65 ( subunit of NF‑κB ) by phase separation of viral replica‑ tion machinery cannot translo‑ cate into the nucleus to activate the downstream transcription of proinflammatory cytokine genes and other antiviral genes [ 129 ] cGAS‑STING signaling Pan‑cancer NF2m‑IRF3 condensates Regulating tumor immunity [ 130 , 131 ] IL‑6 / STAT3 signaling Hepatocellular carcinoma Paraspeckles IL‑6 / STAT3 signaling promotes par‑ aspeckles formation , which favors overactivation of STAT3 [ 132 ] ( See figure on next page . ) Fig . 4 Summary of deregulated phase separations in cancer . A RTK granule formations activate RTK / MAPK signaling pathways to promote tumor proliferation . B DDX21phase separation activates MCM5 , facilitating EMT signaling and modulating metastasis of colon cancer . C LLPS of 53BP1 diminish downstream targets of p53 to evade growth suppressions . D The accumulation of 53BP1 in the nuclear foci is enhanced after DNA damage , activating p53 and regulating cellular senescence . E SUMO ALT‑associated PML bodies on the telomeres facilitate the replicative immortality of cancer cells . F Nuclear condensates ( nYACs ) generated through the LLPS of YTHDC1 ( binding with m6A‑mRNA ) are significantly increased in AML cells . G Mutations in the FERM domain of NF2 ( NF2m ) robustly inhibited STING‑initiated antitumor immunity by forming NF2m‑IRF3 condensates . H PML nuclear bodies ( NBs ) serve as comprehensive ROS sensors associated with antioxidative pathways . I EBNA2 becomes part of BMCs and regulates EBV gene transcriptions . J BRD4 forms condensates with SEs to regulate angiogenesis . K NUP98‑HOXA9 fusion proteins attenuate aberrant chromatin organizations . L m 6 A‑modified androgen receptor ( AR ) mRNA phase separated with YTHDF3 responds to AR pathway inhibition ( ARPI ) stress in prostate cancers . M LLPS of GIRGL‑CAPRIN1‑GLS1 mRNA suppresses GLS1 translation and adapts to an adverse glutamine‑deficient environment . N icFSP1 induces FSP1 condensates to trigger ferroptosis in the dedifferentiation of cancer cells Page 9 of 23 Zheng et al . Journal of Hematology & Oncology ( 2023 ) 16 : 123 signaling pathways [ 19 ] ( Table 3 ) . Next , we review the role of LLPS in tumors based on several hallmarks ( Fig . 4 ) . LLPS promotes the proliferation of cancer cells Cancer cells can undergo unrestricted division [ 20 , 133 – 136 ] , which can occur through gene mutations that Fig . 4 ( See legend on previous page . ) Page 10 of 23 Zheng et al . Journal of Hematology & Oncology ( 2023 ) 16 : 123 activate oncogenic receptor tyrosine kinases ( RTKs ) and the downstream MAPK signaling involving RAS proteins . Adaptor proteins involved in RTK and RAS signaling , such as LAT , GRB2 and SOS , undergo phase separation during RTK activation [ 137 ] . This phenomenon increases the interaction time between SOS and RTK / RAS , provid - ing a mechanism for kinetic proofreading during RTK activation [ 125 , 138 ] and preventing the spontaneous membrane localization of SOS , and the downstream acti - vation of RAS . Interestingly , carcinogenic RTK mutations resulting from chromosomal rearrangements cause the loss of membrane localization but not its ability to stimu - late downstream pathways . Mechanically , these conden - sates can assemble the RAS - activating complex GRB2 / SOS1 , which activates the RAS - MAPK signaling in a membrane - independent manner [ 123 ] . Moreover , RTK fusion oncoprotein granules enable the activation of RTK signaling [ 123 , 139 ] . The close binding to RTK oncopro - tein condensates allows GRB2 to concentrate key down - stream molecules , achieving the constitutive activation of RAS - MAPK signaling in cancer cells ( Fig . 4A ) . Therefore , BMCs provide a new method for modulating cancer - pro - moting signaling in a spatially restricted manner . LLPS promotes the metastasis of tumors The ability to invade and metastasize allows the tumors to develop distantly , and the epithelial – mesenchymal transi - tion ( EMT ) programs are commonly involved [ 140 ] . Acti - vated by EMT , the transcription coactivators YAP and TAZ facilitate metastasis [ 141 , 142 ] . Hu et al . found that YAP fusion proteins undergo LLPS in the nucleus and that the IDR provided by the partner of YAP is required for assembly . This aggregation promotes the YAP / TAZ - specific transcriptions and attenuates metastasis [ 68 ] . Similarly , another study revealed that the phase separa - tion of DDX21 activates MCM5 , thus triggering EMT signaling and modulating the colon cancer metastasis ( Fig . 4B ) [ 143 ] . Besides , SGs are also involved in malig - nant invasion and metastasis . EMT markers Cadherin , Vimentin , Snail and Slug are suppressed under SG core component G3BP1 depletion , implying the role of G3BP1 in tumor metastasis [ 144 ] . Moreover , G3BP modulates mRNA stability under stress conditions and facilitates the invasion of cancer cells [ 145 ] . These carcinogenic mecha - nisms provide new explanations for tumor metastasis , as well as the inspiring ideas for models of cancer progres - sion regulation by the BMCs . LLPS helps evade tumor growth suppression , regulate the aging process , and achieve replicative immortality of tumor cells Cancer cells not only promote their growth but also mod - ify tumor - suppression pathways [ 20 ] . By inhibiting tumor suppressors such as SPOP , p53 , and RB1 [ 146 – 148 ] , can - cer cells escape intrinsic growth limitations . P53 , one of the most well - known tumor suppressors , inhibits tumorigenesis via transcriptional activation , which leads to the disorders of apoptosis , cell cycle , and cell senescence . Tumor - associ - ated stress significantly triggers p53 aggregation [ 149 – 154 ] . These findings demonstrate that the disruption of particu - lar BMCs may cause cancer ( Fig . 4C ) . Further studies are needed to validate this approach with other tumor suppres - sors and to test its potential applications . Cellular senescence is considered an anticancer mecha - nism that maintain homeostasis and is associated with cell cycle arrest . The initiation and maintenance of cellu - lar senescence rely on the frequent damage to the P53 / Rb signaling pathway . Increased accumulation of 53BP1 in the nuclear foci after DNA damage can activate p53 and has recently been shown to regulate the cellular senes - cence via LLPS ( Fig . 4D ) [ 155 ] . Cancer cells can overcome the cell senescence and death via telomerase or alternative methods for length - ening telomeres ( ALT ) [ 156 – 158 ] . Multivalent interac - tions between SUMO and SUMO - interacting motifs were observed in the formation of ALT - associated PML bod - ies on telomeres in cancer stem cells ( Fig . 4E ) [ 159 ] . The fusion of PML bodies enables the clustering of telomere elements and the recruitment of DNA helicases , and other molecular machinery to extend the length of tel - omeres [ 160 ] . This finding suggests that cancer stem cells achieve replicative immortality through the unchecked cell division , and that this process is associated with LLPS . LLPS modulates epigenetic reprogramming of various BMCs Common epigenetic modifications include histone modi - fications , DNA methylation , and RNA interference [ 161 , 162 ] . Interactions between epigenetic modifications and their corresponding reader proteins also exhibit polyvalent interactions . M 6 A , known as the most common mRNA modification [ 163 ] , alters the mRNA structure and inter - acts with multiple other mRNA modifications and proteins . This modification facilitates YTHDF protein phase separa - tion , further contributing to the forming of various RNA – protein granules , including P bodies and SGs [ 74 , 164 ] . In addition , YTHDC1 can undergo LLPS in the nucleus by interacting with m 6 A - modified mRNAs . This interaction results in the formation of nuclear YTHDC1 - m 6 A conden - sates ( nYACs ) , which are significantly enhanced in acute myeloid leukemia ( AML ) cells ( Fig . 4F ) [ 105 ] . LLPS helps cancer cells escape immune destruction and participate in tumor‑associated inflammation The immune system employs the RLR - MAVS and cGAS - STING signaling pathways for protection against Page 11 of 23 Zheng et al . Journal of Hematology & Oncology ( 2023 ) 16 : 123 microbial invasion and support tumor immune surveil - lance [ 165 – 167 ] . However , tumors often escape immune clearance surveillance . Recent findings by Meng et al . revealed that neurofibromin 2 ( NF2 ) facilitates innate immunity by eliminating tank - binding kinase 1 ( TBK1 ) activation . It is the missense mutations in the FERM domain of NF2 ( NF2m ) that robustly inhibit the STING - initiated antitumor immunity via the NF2m - IRF3 con - densates formations ( Fig . 4G ) , suppressing the TBK1 activation [ 130 ] . This offers novel insights into NF2 - related cancer treatments . Notably , inflammation often plays a dual role in can - cer . Overproduced in various inflammatory tissues , the reactive oxygen species ( ROS ) may accelerate the genetic mutations of cells , making them more aggressive and malignant [ 168 ] . However , recent research indicates that the PML NB may function as a sensor for ROS in two ways : protecting cancer cells from excessive ROS or pro - moting ROS - induced apoptosis ( Fig . 4H ) . Given the lack of in - depth research in this field , further tumor microen - vironment exploration is required to understand these processes fully . Tumor - associated viruses , such as human papilloma - virus , Kaposi sarcoma herpesvirus , and Epstein – Barr virus ( EBV ) , influence tumor progression through LLPS [ 169 – 171 ] . In EBV proteins such as EBNA2 and EBNALP , LLPS regulates host gene expression , forming biomol - ecule condensates at Runx3 and MYC SE sites to regulate viral and cellular gene transcription ( Fig . 4I ) . Further , the LLPS of EBNA2 can influence the alternative splicing of the pre - MPPE1 gene in cancer [ 170 ] . LLPS induce vasculature of the tumors Vascularization , also known as angiogenesis , is cru - cial for supplying tumors with nutrients and oxygen for growth . Vascular endothelial growth factor ( VEGF ) is the leading factor responsible for rapid nutrient supply . Mounting evidence has indicated a correlation between BMC formation and angiogenesis . For example , the con - stitutive expression of the transcription factor ( TF ) MYC in metastasizing cells can lead to VEGF transcription by potentially forming phase - separated transcription con - densates , promoting promotes angiogenesis [ 172 ] . Simi - larly , the use of 1 , 6 - hexanediol , an inhibitor of LLPS , has recently been shown to regulate angiogenesis by inhib - iting cyclin A1 - related endothelial functions as well as condensates with BRD4 , indicating that targeting con - densates can block critical reactions ( Fig . 4J ) [ 173 , 174 ] . Genomic arrangements initiate LLPS Genomic instability contributes to tumor progression . Genomic translocations and rearrangements can lead to the fusion between the IDR of one protein and the DNA - or chromatin - binding domain of another [ 175 ] . This fusion acts as a TF , eliciting LLPS and attracting additional partners to initiate transcriptional programs that ultimately contribute to tumorigenesis . A typical example is the NUP98 fusion oncoprotein ( FO ) , which occurs in 50 % of patients with chemotherapy - resistant AML [ 176 – 179 ] . FOs demonstrate that malignancies establish cancerous TF condensates [ 83 , 180 , 181 ] and attenuate aberrant chromatin organization ( Fig . 4K ) . LLPS of SGs assist in avoiding cell death of cancer cells under the stress Cancer cells can escape apoptosis by forming SGs ( a form of MLOs ) when exposed to extreme conditions , such as high temperatures , toxins , mechanical damage , or other stresses . For example , the Y - box binding protein 1 ( YB - 1 ) interacts with the 5’ - untranslated region ( UTR ) of G3BP1 [ 182 ] , leading to the increased expression of G3BP1 and SGs , which is elevated in human sarcomas [ 183 – 185 ] . Consequently , these cancer cells survive hyperproliferation , chemotherapy and other various stressful conditions . Additional studies on prostate can - cer have demonstrated that the m 6 A - modified androgen receptor ( AR ) mRNA phase separated with YTHDF3 , while the unmodified AR mRNA phase separated with G3BP1 to survive AR pathway inhibition stress ( Fig . 4L ) [ 186 ] . Collectively , SGs may serve as novel targets for cancer biology investigations . LLPS regulates cellular metabolisms of cancer cells Malignant cells undergo metabolic reprogramming [ 187 ] , thereby attracting considerable interest in tumor - related research in the past decades [ 188 ] . For example , the reduction of glutaminase - 1 ( GLS1 ) enables cancer cells to survive under prolonged glutamine deprivation stress [ 189 , 190 ] . Wang et al . reported that the lncRNA GIRGL promotes the LLPS of GIRGL - CAPRIN1 - GLS1 mRNA to suppress GLS1 translation , thus adapting to an adverse glutamine - deficient environment ( Fig . 4M ) [ 191 ] . CAPRIN1 , an RNA - binding protein involved in the SG formation via LLPS , plays a role in this metabolic adaptation . Therefore , alteration of cell adaptation to an adverse metabolic environment is possible by targeting condensates . Potential role of LLPS in the phenotypic plasticity of tumorigenesis Tumor cells often exhibit phenotypic plasticity to evade terminal differentiation . This plasticity includes the dedifferentiation , the differentiation inhibition , and the transdifferentiation [ 20 ] . During dedifferentiation , spe - cific malignant cells become sensitized to ferroptosis [ 192 – 194 ] , a form of cell death . Nakamura et al . [ 195 ] Page 12 of 23 Zheng et al . Journal of Hematology & Oncology ( 2023 ) 16 : 123 first demonstrated that the novel FSP1 inhibitor , icFSP1 impairs cell proliferation and induces FSP1 condensa - tion to trigger ferroptosis in cancer cells ( Fig . 4N ) . This highlights the role of iron in tumor progression and the dependence of cancer cells on iron in drug - resistant states . Clinical applications of LLPS in oncologic fields Potential of LLPS in cancer treatments Considering that various regulatory mechanisms of LLPS are closely associated with tumorigenesis , it is impera - tive to explore therapeutic approaches against abnor - mal LLPS . These strategies can be categorized into three main approaches ( Table 4 ) . Disruptions of the formation of BMCs The direct disruption of the driving force behind LLPS offers a straightforward approach ( Fig . 5A ) . For example , certain drugs can intervene in the LLPS process by target - ing IDRs of proteins . Notably , the anti - HIV drug elvitegra - vir directly binds to the highly disordered steroid receptor coactivator 1 , effectively inhibiting oncogene YAP tran - scription by disrupting SRC1 / YAP / TEAD condensates ( Table 4 ) [ 117 ] . Similarly , Yu et al . reported that the nuclear translocation of YAP and LLPS are affected by IFN treat - ment in cancer cells . Therefore , interrupting the LLPS of YAP can inhibit cancer cell proliferation and enhance the immune response , indicating its potential as a predictive biomarker in immune checkpoint blockade [ 67 ] . Further , altering interactions between LCDs indirectly modulates the transcriptional subunits , thus offering a promising approach for targeting disease - causing TFs . Modifications of PTMs and physicochemical conditions As previously mentioned , certain post - transitional modi - fications and physiochemical conditions contribute to LLP dynamics ( Fig . 5B ) . For example , nYACs protect mRNAs from degradation and strengthen the role of YTHDC1 in leukemogenesis , which inspires us to dis - rupt m 6 A to violate deleterious condensates [ 105 ] . Fur - ther , studies have reported that modulating PTMs in LLPS proteins is also significant [ 25 , 96 , 102 , 218 – 221 ] . In the case of colon cancer , SENP1 has been reported to decrease RNF168 SUMOylation , inhibit nuclear con - densate formation , and promote DNA damage repair ( DDR ) and drug resistance . Given these observations , strategies to curb the harmful effects of protein aggrega - tion by influencing protein modifications warrant further investigation . Drug interventions of the dynamics of condensates Drugs can significantly influence the dynamics of the condensates , affecting their anticancer effects and potentially leading to drug resistance ( Fig . 5C ) . For exam - ple , in luminal breast cancer , tamoxifen accumulates in MED1 condensates , preventing the incorporation of ERα into these condensates , partially inhibiting cancer pro - gression . However , when MED1 is overexpressed , larger condensates dilute the drug concentration , ultimately leading to the development of resistance [ 202 ] . Several drugs , such as cisplatin , mitoxantrone , and THZ1 , selec - tively partition into BMCs formed by MED1 ( Table 4 ) . Drug resistance can occur via selective partitioning into BMCs or changes in properties . Notably , cisplatin exerts its anticancer activity by dissolving SEs , indicating that changes in the condensate properties may improve thera - peutic outcomes [ 202 ] . This finding highlights the poten - tial of altering the properties of condensates to improve therapeutic outcomes . In some cases , promoting the formation of BMCs may have therapeutic effects . For example , in APL , fusion proteins of PML - retinoic acid receptor α ( RARA ) hinder the assembly of PML bodies and result in the suppression of differentiation genes . Successful APL treatment involves the restoration of PML nuclear bodies using empirically discovered drugs ( Table 4 ) [ 222 ] . Roles of LLPS in vesicular trafficking and drugs’ delivery Although LLPS and traditional vesicles are two different concepts with distinctive definitions , the vesicular traf - ficking role of LLPS is still rarely described and attrac - tive . Conventional approaches typically utilize nanoscale carriers that are confined within the compartments of the intranuclear body . Nevertheless , recent findings have demonstrated that micron - scale polypeptide clusters , formed through phase separation , possess the ability to traverse the cell membrane via a non - canonical endocytic pathway . These clusters undergo glutathione - induced release of their cargo and exhibit the capacity to rapidly incorporate various macromolecules into microdroplets , such as RNA , small peptides and enzymes [ 223 ] . Loaded with polysomes , they can provide new approaches for vaccine carriers based on mRNAs and intracellular trans - portations for cancer treatments . Likewise , as previously mentioned , droplets of drugs formed by LLPS can unexpectedly raise the inner drug concentration up to 600 times higher than that outside the condensate [ 202 ] . Furthermore , MED1 predomi - nantly acts on oncogene promoters , thereby enabling cisplatin to ultimately target the corresponding DNA through its toxic platinum atoms , effectively assaulting the vital components of the cancer cells . Besides , the phosphopeptide KYp has been observed to induce LLPS level at the cell membrane , thus enhancing the permea - tion and internalization of the peptide drug [ 224 ] . KYp has the ability to interact with alkaline phosphatase , Page 13 of 23 Zheng et al . Journal of Hematology & Oncology ( 2023 ) 16 : 123 T a b l e 4 S u mm a r y o f s t r a t e g i e s a n d d r u g s t h a t u s e p h a s e s e p a r a t i o n t o i n t e r v e n e i n t u m o r i g e n e s i s a n d p r o g r e ss i o n T a r g e t i n g s t r a t e g y D r u g / m o l e c u l e s T u m o r t y p e s A ss o c i a t e d p r o t e i n / c o n d e n s a t e M e c h a n i s m o f a c t i o n R e f e r e n c e s D i s r u p t i o n s o f t h e B M C s ’ f o r m a t i o n s II A 4 B 20 , II A 6 B 17 , m y c m y c i n ‑ 1 / 2 P a n ‑ c a n c e r M y c P r e v e n t i n g t h e M y c / M a x d i m e r i z a t i o n i nh i b i t M y c ‑ i n d u c e d m a l i g n a n t t r a n s f o r ‑ m a t i o n [ 196 ] Y K ‑ 4 – 279 E W S E W S ‑ F L I 1 f u s i o n B i n d i n g t o t h e I D R o f t h e o n c o g e n i c t r a n s c r i p t i o n f a c t o r E W S ‑ F L I 1 a n d p r e ‑ v e n t s t h e i n t e r a c t i o n b e t w ee n E W S ‑ F L I 1 a n d R N A h e l i c a s e A , t h e r e b y s l o w i n g d o w n E W S c e ll g r o w t h [ 197 ] e l v i t e g r a v i r L u n g c a n c e r S R C 1 D i r e c t l y b i n d i n g t o t h e h i g h l y d i s o r ‑ d e r e d S R C 1 a n d e ff e c t i v e l y i nh i b i t Y A P o n c o g e n e t r a n s f e r b y d i s r u p t i n g l i q u i d – l i q u i d s e p a r a t i o n i n S R C 1 / Y A P / T E A D c o n d e n s a t e s [ 117 ] C 108 B r e a s t c a n c e r G 3 B P 2 ( S G c o r e c o m p o n e n t ) D i m i n i s h i n g t h e r o l e o f S G c o r e c o m p o ‑ n e n t G 3 B P 2 i n b r e a s t c a n c e r i n i t i a t i o n a n d i m p r o v e t h e e ffi c a c y o f c h e m o ‑ t h e r a p y d r u g s [ 198 ] 2142 – R 8 p e p t i d e P a n ‑ c a n c e r K A T 8 – I R F 1 c o n d e n s a t e s d i s r u p t t h e f o r m a t i o n o f K A T 8 – I R F 1 c o n d e n s a t e s , s u b s e q u e n t l y s u pp r e ss i n g P D ‑ L 1 e x p r e ss i o n a n d e nh a n c i n g a n t i t u ‑ m o r i mm u n i t y i n v i t r o a n d i n v i v o [ 198 ] B A Y 249716 P a n ‑ c a n c e r p 53 I n d u c i n g c o n d e n s a t e f o r m a t i o n o f D N A ‑ b i n d i n g d e f e c t i v e m u t a n t s ; d i ss o l v e n u c l e a r c o n d e n s a t e s o f s t r u c t u r a l m u t a n t s ; c o v a l e n t b i n d e r s [ 199 ] B A Y 1892005 A v r a i n v i ll a m i d e A m l N P M 1 R e s t o r i n g n u c l e o l a r l o c a l i z a t i o n o f c y t o ‑ p l a s m i c N P M 1 m u t a n t ; c o v a l e n t b i n d e r [ 200 ] S H P 099 R T K ‑ d r i v e n h u m a n c a n c e r S H P 2 S t a b i l i z i n g S H P 2 i n a n a u t o ‑ i nh i b i t e d c o n f o r m a t i o n a n d s u pp r e ss i n g R A S – E R K s i g n a ll i n g t o i nh i b i t t h e p r o l i f e r a t i o n o f r e c e p t o r ‑ t y r o s i n e ‑ k i n a s e ‑ d r i v e n h u m a n c a n c e r c e ll s [ 201 ] E T 070 R T K ‑ d r i v e n h u m a n c a n c e r S H P 2 I nh i b i t i n g t h e p h a s e s e p a r a t i o n a b i l i t y o f S H P 2 m u t a n t s b y l o c k i n g S H P 2 i n t h e “ o ff ” c o n f o r m a t i o n [ 126 ] J Q 1 B r e a s t c a n c e r a n d c o l o n c a n c e r B E T f a m i l y o f b r o m o d o m a i n p r o t e i n s P a r t i t i o n s i n t o t r a n s c r i p t i o n a l c o n ‑ d e n s a t e s ; d i ss o l v i n g M E D 1 n u c l e a r c o n d e n s a t e s [ 202 ] E P I ‑ 001 P r o s t a t e c a n c e r A n d r o g e n r e c e p t o r D i ss o l v i n g a n d r o g e n r e c e p t o r ‑ r i c h t r a n ‑ s c r i p t i o n a l c o n d e n s a t e s [ 203 ] L e p t o m y c i n B L e u k e m i a C R M 1 I nh i b i t i n g f o r m a t i o n o f a b e rr a n t N U P 98 – H O X A 9 t r a n s c r i p t i o n a l c o n d e n s a t e s [ 204 ] Page 14 of 23 Zheng et al . Journal of Hematology & Oncology ( 2023 ) 16 : 123 T a b l e 4 ( c o n t i n u e d ) T a r g e t i n g s t r a t e g y D r u g / m o l e c u l e s T u m o r t y p e s A ss o c i a t e d p r o t e i n / c o n d e n s a t e M e c h a n i s m o f a c t i o n R e f e r e n c e s R i b a v i r i n P r o s t a t e c a n c e r O C T 4 / A R / F O X A 1 , O C T 4 / N R F 1 I nh i b i t i n g t h e f o r m a t i o n o f O C T 4 ‑ A R a x i s b y m o d u l a t i n g O C T 4 c o n d e n s a t e s i n t h e n u c l e u s [ 205 ] T i n ( I V ) o x o c h l o r i d e ‑ d e r i v e d c l u s t e r P a n ‑ c a n c e r I D R o f T A F 2 i n T F II D D i s r u p t i n g t r a n s c r i p t i o n i n i t i a t i o n b y s e l e c t i v e l y i m p a i r i n g t h e f u n c t i o n o f T F II D [ 206 ] P R I M A ‑ 1 ; R e A C p 53 O v a r i a n c a r c i n o m a p 53 m u t a n t s I n d u c t i o n o f c e ll c y c l e a rr e s t i n c a n c e r c e ll s w i t h m u t a n t p 53 b y r e s t o r i n g t h e n a t i v e c o n f o r m a t i o n o f a gg r e g a t e d m u t a n t p 53 p r o t e i n s [ 207 ] P C G B r e a s t c a n c e r I D R o f BR D 4 S u pp r e ss i o n o f BR D 4 ‑ d e p e n d e n t g e n e t r a n s c r i p t i o n [ 208 ] b i s ‑ A N S C o l o n c a n c e r L C D o f T D P ‑ 43 h i g h c o n c e n t r a t i o n s o f b i s ‑ A N S i nh i b i t T D P ‑ 43 c o n d e n s a t e a ss e m b l y , w h e r e a s l o w c o n c e n t r a t i o n s f a c i l i t a t e t h e f o r m a ‑ t i o n o f l i q u i d d r o p l e t s [ 209 ] M o d i fi c a t i o n s o f P T M s a n d p h y s i c o ‑ c h e m i c a l c o n d i t i o n s S I ‑ 2 M u l t i p l e m y e l o m a S R C 3 / N S D 2 c o n d e n s a t e P h a s e s e p a r a t i o n o f S R C 3 m e d i a t e d b y h i s t o n e m e t h y l t r a n s f e r a s e N S D 2 l e a d s t o r e s i s t a n c e t o b l e i t i n i b i n m u l t i p l e m y e l o m a , w h e r e a s t h e i nh i b i t o r S I ‑ 2 I nh i b i t s f o r m a t i o n o f d r u g ‑ r e s i s t a n t S R C 3 / N S D 2 c o n d e n s a t e s a n d i m p r o v e s t h e t h e r a p e u t i c e ffi c a c y o f b l e i t i n i b [ 210 ] O l a p a r i b P a n ‑ c a n c e r P A R P 1 / 2 D N A r e p a i r c o n d e n ‑ s a t e I nh i b i t i n g P A R P 1 / 2 a n d t h u s i n t e r f e r e s w i t h t h e f o r m a t i o n o f P A R y l a t i o n r e l a t e d D N A r e p a i r c o n d e n s a t e s [ 211 ] G S K ‑ J 4 O s t e o s a r c o m a H O X B 8 / F O S L 1 C R C T h e H 3 K 27 d e m e t h y l a s e i nh i b i t o r G S K ‑ J 4 , i nh i b i t s t h e C R C p h a s e s e p a r a t i o n a n d r e s u l t s i n m e t a s t a s i s s u pp r e ss i o n a n d r e ‑ s e n s i t i v i t y t o c h e m o t h e r a p y d r u g s [ 212 ] i c F S P 1 M e l a n o m a a n d l u n g c a n c e r h F S P 1 I n d u c i n g p h a s e s e p a r a t i o n o f m y r i s ‑ t o y l a t e d h F S P 1 , t h u s p r o m o t i n g f e rr o p ‑ t o s i s a n d i nh i b i t t u m o r p r o l i f e r a t i o n s [ 195 ] G S K ‑ 626616 P a n ‑ c a n c e r D Y R K 3 I nh i b i t P R A S 40 p h o s p h o r y l a t i o n a n d r e s t r a i n m T O R C 1 s i g n a l i n g i n S G s [ 213 ] J Q 1 A M L BR D 4 R e l e a s e t h e M e d i a t o r c o m p l e x f r o m S E s [ 214 ] S G C 0946 M LL l e u k e m i a D O T 1 L I nh i b i t h i s t o n e H 3 K 79 m e t h y l a t i o n a n d h i s t o n e H 4 a c e t y l a t i o n [ 215 ] Page 15 of 23 Zheng et al . Journal of Hematology & Oncology ( 2023 ) 16 : 123 T a b l e 4 ( c o n t i n u e d ) T a r g e t i n g s t r a t e g y D r u g / m o l e c u l e s T u m o r t y p e s A ss o c i a t e d p r o t e i n / c o n d e n s a t e M e c h a n i s m o f a c t i o n R e f e r e n c e s T H Z 1 P a n ‑ c a n c e r C D K 7 I nh i b i t R N A P II p h o s p h o r y l a t i o n [ 216 ] T H Z 531 P a n ‑ c a n c e r C D K 12 a n d C D K 13 I nh i b i t R N A P II p h o s p h o r y l a t i o n [ 217 ] D r u g i n t e r v e n t i o n s a n d d i s t r i b u t i o n s o f t h e d y n a m i c s o f c o n d e n s a t e s C i s p l a t i n B r e a s t c a n c e r a n d c o l o n c a n c e r M E D 1 t r a n s c r i p t i o n a l c o n d e n ‑ s a t e s P a r t i t i o n s i n t o t r a n s c r i p t i o n a l c o n d e n ‑ s a t e s ; d i ss o l v e s M E D 1 a n d BR D 4 n u c l e a r c o n d e n s a t e s [ 202 ] T a m o x i f e n b r e a s t c a n c e r a n d c o l o n c a n c e r E s t r o g e n r e c e p t o r S e l e t i v e l y p a r t i t i o n s i n t o t r a n s c r i p t i o n a l c o n d e n s a t e s [ 202 ] m i t o x a n t r o n e b r e a s t c a n c e r a n d c o l o n c a n c e r E s t r o g e n r e c e p t o r S e l e t i v e l y p a r t i t i o n s i n t o t r a n s c r i p t i o n a l c o n d e n s a t e s [ 202 ] P M L ‑ r e t i n o i c a c i d r e c e p t o r α A P L P M L b o d i e s H i n d e r i n g t h e a ss e m b l y o f P M L b o d i e s a n d r e s u l t i n t h e s u pp r e ss i o n o f d i ff e r e n ‑ t i a t i o n g e n e s . S u cc e ss f u l A P L t r e a t m e n t i n v o l v e s t h e r e s t o r a t i o n o f P M L n u c l e a r b o d i e s u s i n g e m p i r i c a ll y d i s c o v e r e d d r u g s [ 109 ] B M C , b i o m o l e c u l a r c o n d e n s a t e ; E W S , E w i n g s a r c o m a ; I D R , i n t r i n s i c a ll y d i s o r d e r e d r e g i o n ; S G , s t r e ss g r a n u l e , R T K , r e c e p t o r - t y r o s i n e - k i n a s e ; C R C , c o r e r e g u l a t o r y c i r c u i t r y ; M LL , m i x e d l i n e a g e l e u k e m i a ; P M L , P r o m y e l o c y t i c l e u k e m i a p r o t e i n ; A P L , a c u t e p r o m y e l o c y t i c l e u k e m i a Page 16 of 23 Zheng et al . Journal of Hematology & Oncology ( 2023 ) 16 : 123 resulting in the dephosphorylation and in situ self - assembly at the cell membrane [ 224 ] . The process induces the aggregation of alkaline phosphatase and the separation of proteolipid phases at the membrane , ulti - mately enhancing membrane leakage and facilitating the entry of the peptide drug . These great discoveries provide inspirations for designing drug delivery sys - tems and more similar ideas are worth exploring . Conclusions and future perspectives In the past decades , crucial advances have been made in figuring out the role of LLPS in a variety of cellular pro - cesses and biological functions . Since the update of the new version of “Hallmarks of cancer 2022” , cancer hall - marks and their enabling characteristics help distill the oncogenic complexity into an evidently logical science , which have been gradually proven to be closely asso - ciated with LLPS . In this review , we summarize the mechanism of LLPS formations , recent discoveries and the individual role of LLPS in oncology . These findings collectively reveal its vital role in solving undruggable targets and multiple clinical problems . The role of specific proteins and post - translational mechanisms in the formation and regulation of LLPS are being investigated . These efforts aim to identify abnormal conditions and gain insights into the mechanisms regu - lating the formation of the condensates . These studies have already begun to help find new strategies for target - ing disease - related condensates . Notably , while previ - ous drugs were designed to inhibit each protein directly , LLPS offers a novel and unexpected possibility of inter - fering with the pathological process and does not neces - sitate targeting each protein individually . This approach achieves disruption of the condensates formed by IDRs of TFs . Fig . 5 Potential approaches to developing new cancer treatments by regulating BMCs . A Targeting driving forces to disrupt condensate formation . B Changing the modifications of components or physicochemical interaction . C Drug concentrations influenced by dynamic condensates Page 17 of 23 Zheng et al . Journal of Hematology & Oncology ( 2023 ) 16 : 123 Despite the steady progress in targeting BMCs using LLPS , several fundamental questions need to be answered . For example , what are the functional differ - ences between LLPS - formed assemblies and typical protein complexes ? What factors contribute to dynamic condensation and decondensation , and how do different BMCs communicate in vitro and in vivo ? Moreover , the role of PTMs in tumorigenesis requires further explora - tion ( Table 5 ) . Clarifying these aspects will improve our understanding of the conversion of physiological into pathological condensates in cancer . Future research will require collaborative efforts , innovative approaches , and a holistic approach to studying cancer - associated LLPS , which may lead to novel anti - tumor therapies directly targeting BMCs . Abbreviations ALT Alternative lengthening of telomeres ALK Anaplastic lymphoma kinase AML Acute myeloid leukemia AR Androgen receptor AS Alternatively spliced APL Acute promyelocytic leukemia BMCs Biomolecular condensates DDR DNA damage repair EBV Epstein – Barr virus EMT Epithelial – mesenchymal transition FO Fusion oncoproteins GLS1 Glutaminase‑1 IDR Intrinsically disordered regions LCDs Low‑complexity domains LLPS Liquid‑liquid phase separation MLOs Membrane‑less organelles NB Nuclear body NF2 Neurofibromin 2 N‑WASP Neural Wiskott—Aldrich Syndrome PRM Proline‑rich motif PTM Post‑translational modification RARA Retinoic acid receptor α RBPs RNA‑binding proteins ROS Reactive oxygen species RTKs Receptor tyrosine kinases SEs Super‑enhancers SERBP1 SERPINE1 mRNA‑binding protein 1 SG Stress granule SPOP Speckled POZ protein TF Transcription factor UTR Untranslated region VEGF Vascular endothelial growth factor Acknowledgements The figures are created with Biorender . com . Author contributions L‑WZ conceived and drafted the manuscript and drew the figures . K‑DY and C – CL discussed the concepts and provided valuable suggestions and revised the manuscript . Funding The authors acknowledge funding from the National Natural Science Foundation of China ( grant number : 82325042 , 82203860 , 82072916 ) , and National Key R & D Program of China ( grant number : 2023YFC3404100 , 2023YFC2506400 ) , and Shanghai Municipal Education Commission Scientific Research Innovation Project ( grant number : 2023‑05‑50 ) , Wu Jieping Medical Foundation Research Project ( grant number : 32067502023‑18‑29 ) . Availability of data and materials Not applicable . Declarations Ethics approval and consent to participate Not applicable . Consent for publication Not applicable . Table 5 Outlook and reflection on the future of the field Critical issues in the current development of oncogenic LLPS Outlook and reflection on the future / possible solutions to the questions What are the functional differences between LLPS‑formed assemblies and typical protein complexes ? What factors contribute to dynamic condensation and decondensation , and how do different BMCs communicate in vitro and in vivo ? The target protein molecules and signaling pathways discovered through LLPS method are a class of molecules that can form condensates spontaneously due to their own unique properties or under different environmental conditions . LLPS is essentially an energy saving process in the organisms . Further functional differences between LLPS ‐ formed assemblies and canonical protein complexes deserve investigations Is there other function of PTMs in tumorigenesis and tumor progressions ? Further studies on phase separation on the basis of proteomics and PTMs are needed Detections of BMCs / MLOs in tumor samples and clinicopathologic asso‑ ciations with cancer patients are deficient Clinicopathologic tests should be involved in further studies How do environment conditions inducing condensate assemblies being applied to clinical practice ? Perhaps changing the environment conditions can dynamically alter the condensation and decondensation of the BMC , which will make sense in drug deliveries . A greater understanding of the opportunities for tar‑ geting LLPS condensates in the pharmaceutical intervention should be obtained Is there any new convenient method to probe and control ( induce , dis‑ solve , or tune ) the endogenous condensates ? The partitioning of anticancer drugs in subcellular condensates is also dominant for drug efficacy . According to this characteristic , we can detect the distribution of drugs in cells or by linking drugs to molecules that can specifically aggregate in liquid droplets How to make use of LLPS to enhance the efficiency of drugs in clinical practice ? Page 18 of 23 Zheng et al . Journal of Hematology & Oncology ( 2023 ) 16 : 123 Competing Interests The authors declare no conflict of interest . Received : 7 November 2023 Accepted : 12 December 2023 References 1 . Zhang H , Elbaum‑Garfinkle S , Langdon EM , Taylor N , Occhipinti P , Bridges AA , Brangwynne CP , Gladfelter AS . RNA controls PolyQ protein phase transitions . Mol Cell . 2015 ; 60 : 220 – 30 . 2 . Pederson T The nucleolus , Cold Spring Harb Perspect Biol , 3 ( 2011 ) 3 . Shimobayashi SF , Ronceray P , Sanders DW , Haataja MP , Brangwynne CP . Nucleation landscape of biomolecular condensates . Nature . 2021 ; 599 : 503 – 6 . 4 . Lafontaine DLJ , Riback JA , Bascetin R , Brangwynne CP . The nucleolus as a multiphase liquid condensate . Nat Rev Mol Cell Biol . 2021 ; 22 : 165 – 82 . 5 . Wheeler JR , Matheny T , Jain S , Abrisch R , Parker R . Distinct stages in stress granule assembly and disassembly . Elife . 2016 ; 5 : e18413 . 6 . Wang M , Tao X , Jacob MD , Bennett CA , Ho JJD , Gonzalgo ML , Audas TE , Lee S . Stress‑induced low complexity RNA activates physiological amyloidogenesis . Cell Rep . 2018 ; 24 : 1713‑1721 . e1714 . 7 . Gui X , Luo F , Li Y , Zhou H , Qin Z , Liu Z , Gu J , Xie M , Zhao K , Dai B , Shin WS , He J , He L , Jiang L , Zhao M , Sun B , Li X , Liu C , Li D . Structural basis for reversible amyloids of hnRNPA1 elucidates their role in stress gran‑ ule assembly . Nat Commun . 2019 ; 10 : 2006 . 8 . Liu S , Wang T , Shi Y , Bai L , Wang S , Guo D , Zhang Y , Qi Y , Chen C , Zhang J , Zhang Y , Liu Q , Yang Q , Wang Y , Liu H . USP42 drives nuclear speckle mRNA splicing via directing dynamic phase separation to promote tumorigenesis . Cell Death Differ . 2021 ; 28 : 2482 – 98 . 9 . Liao SE , Regev O . Splicing at the phase‑separated nuclear speckle interface : a model . Nucleic Acids Res . 2021 ; 49 : 636 – 45 . 10 . Guo YE , Manteiga JC , Henninger JE , Sabari BR , Dall’Agnese A , Hannett NM , Spille JH , Afeyan LK , Zamudio AV , Shrinivas K , Abraham BJ , Boija A , Decker TM , Rimel JK , Fant CB , Lee TI , Cisse II , Sharp PA , Taatjes DJ , Young RA . Pol II phosphorylation regulates a switch between transcriptional and splicing condensates . Nature . 2019 ; 572 : 543 – 8 . 11 . Banani SF , Lee HO , Hyman AA , Rosen MK . Biomolecular conden‑ sates : organizers of cellular biochemistry . Nat Rev Mol Cell Biol . 2017 ; 18 : 285 – 98 . 12 . Hyman AA , Weber CA , Jülicher F . Liquid‑liquid phase separation in biol‑ ogy . Annu Rev Cell Dev Biol . 2014 ; 30 : 39 – 58 . 13 . Xiao Q , McAtee CK , Su X . Phase separation in immune signalling . Nat Rev Immunol . 2022 ; 22 : 188 – 99 . 14 . Shin Y , Brangwynne CP . Liquid phase condensation in cell physiology and disease . Science . 2017 ; 357 : eaaf4382 . 15 . Roden C , Gladfelter AS . RNA contributions to the form and function of biomolecular condensates . Nat Rev Mol Cell Biol . 2021 ; 22 : 183 – 95 . 16 . Langdon EM , Gladfelter AS . A new lens for RNA localization : liquid‑ liquid phase separation . Annu Rev Microbiol . 2018 ; 72 : 255 – 71 . 17 . Alberti S . Phase separation in biology . Curr Biol . 2017 ; 27 : R1097‑r1102 . 18 . Wang B , Zhang L , Dai T , Qin Z , Lu H , Zhang L , Zhou F . Liquid‑liquid phase separation in human health and diseases . Signal Transduct Target Ther . 2021 ; 6 : 290 . 19 . Tong X , Tang R , Xu J , Wang W , Zhao Y , Yu X , Shi S . Liquid‑liquid phase separation in tumor biology . Signal Transduct Target Ther . 2022 ; 7 : 221 . 20 . Hanahan D . Hallmarks of cancer : new dimensions . Cancer Discov . 2022 ; 12 : 31 – 46 . 21 . Mehta S , Zhang J . Liquid‑liquid phase separation drives cellular func‑ tion and dysfunction in cancer . Nat Rev Cancer . 2022 ; 22 : 239 – 52 . 22 . Nozawa RS , Yamamoto T , Takahashi M , Tachiwana H , Maruyama R , Hirota T , Saitoh N . Nuclear microenvironment in cancer : control through liquid‑liquid phase separation . Cancer Sci . 2020 ; 111 : 3155 – 63 . 23 . Uversky VN . Intrinsically disordered proteins in overcrowded milieu : membrane‑less organelles , phase separation , and intrinsic disorder . Curr Opin Struct Biol . 2017 ; 44 : 18 – 30 . 24 . Boeynaems S , Alberti S , Fawzi NL , Mittag T , Polymenidou M , Rous‑ seau F , Schymkowitz J , Shorter J , Wolozin B , Van Den Bosch L , Tompa P , Fuxreiter M . Protein phase separation : a new phase in cell biology . Trends Cell Biol . 2018 ; 28 : 420 – 35 . 25 . Boija A , Klein IA , Young RA . Biomolecular condensates and cancer . Cancer Cell . 2021 ; 39 : 174 – 92 . 26 . Brangwynne CP , Eckmann CR , Courson DS , Rybarska A , Hoege C , Gharakhani J , Jülicher F , Hyman AA . Germline P granules are liquid droplets that localize by controlled dissolution / condensation . Science . 2009 ; 324 : 1729 – 32 . 27 . Iglesias V , Santos J , Santos‑Suárez J , Pintado‑Grima C , Ventura S . SGnn : a web server for the prediction of prion‑like domains recruitment to stress granules upon heat stress . Front Mol Biosci . 2021 ; 8 : 718301 . 28 . Hou C , Wang X , Xie H , Chen T , Zhu P , Xu X , You K , Li T . PhaSepDB in 2022 : annotating phase separation‑related proteins with droplet states , co‑ phase separation partners and other experimental information . Nucleic Acids Res . 2022 ; 51 ( 2023 ) : D460‑d465 . 29 . Oates ME , Romero P , Ishida T , Ghalwash M , Mizianty MJ , Xue B , Dosztányi Z , Uversky VN , Obradovic Z , Kurgan L , Dunker AK , Gough J . D 2 P 2 : database of disordered protein predictions . Nucleic Acids Res . 2013 ; 41 : D508‑516 . 30 . Lancaster AK , Nutter‑Upham A , Lindquist S , King OD . PLAAC : a web and command‑line application to identify proteins with prion‑like amino acid composition . Bioinformatics . 2014 ; 30 : 2501 – 2 . 31 . Ning W , Guo Y , Lin S , Mei B , Wu Y , Jiang P , Tan X , Zhang W , Chen G , Peng D , Chu L , Xue Y . DrLLPS : a data resource of liquid‑liquid phase separa‑ tion in eukaryotes . Nucleic Acids Res . 2020 ; 48 : D288‑d295 . 32 . Mészáros B , Erdős G , Szabó B , Schád É , Tantos Á , Abukhairan R , Horváth T , Murvai N , Kovács OP , Kovács M , Tosatto SCE , Tompa P , Dosztányi Z , Pancsa R . PhaSePro : the database of proteins driving liquid‑liquid phase separation . Nucleic Acids Res . 2020 ; 48 : D360‑d367 . 33 . Oughtred R , Rust J , Chang C , Breitkreutz BJ , Stark C , Willems A , Boucher L , Leung G , Kolas N , Zhang F , Dolma S , Coulombe‑Huntington J , Chatr‑ Aryamontri A , Dolinski K , Tyers M . The BioGRID database : a compre‑ hensive biomedical resource of curated protein , genetic , and chemical interactions . Protein Sci . 2021 ; 30 : 187 – 200 . 34 . Li Q , Peng X , Li Y , Tang W , Zhu J , Huang J , Qi Y , Zhang Z . LLPSDB : a database of proteins undergoing liquid‑liquid phase separation in vitro . Nucleic Acids Res . 2020 ; 48 : D320‑d327 . 35 . Go CD , Knight JDR , Rajasekharan A , Rathod B , Hesketh GG , Abe KT , Youn JY , Samavarchi‑Tehrani P , Zhang H , Zhu LY , Popiel E , Lambert JP , Coyaud É , Cheung SWT , Rajendran D , Wong CJ , Antonicka H , Pelletier L , Palazzo AF , Shoubridge EA , Raught B , Gingras AC . A proximity‑dependent biotinylation map of a human cell . Nature . 2021 ; 595 : 120 – 4 . 36 . Orti F , Fernández ML , Marino‑Buslje C MLOsMetaDB , a meta‑database to centralize the information on Liquid‑liquid phase separation proteins and Membraneless organelles , bioRxiv , ( 2023 ) 37 . Bolognesi B , Lorenzo Gotor N , Dhar R , Cirillo D , Baldrighi M , Tartaglia GG , Lehner B . A concentration‑dependent liquid phase separa‑ tion can cause toxicity upon increased protein expression . Cell Rep . 2016 ; 16 : 222 – 31 . 38 . Vernon RM , Chong PA , Tsang B , Kim TH , Bah A , Farber P , Lin H , Forman‑ Kay JD . Pi‑Pi contacts are an overlooked protein feature relevant to phase separation . Elife . 2018 ; 7 : e31486 . 39 . Liu M , Li H , Luo X , Cai J , Chen T , Xie Y , Ren J , Zuo Z . RPS : a compre‑ hensive database of RNAs involved in liquid‑liquid phase separation . Nucleic Acids Res . 2022 ; 50 : D347‑d355 . 40 . Zhu H , Fu H , Cui T , Ning L , Shao H , Guo Y , Ke Y , Zheng J , Lin H , Wu X , Liu G , He J , Han X , Li W , Zhao X , Lu H , Wang D , Hu K , Shen X . RNAPhaSep : a resource of RNAs undergoing phase separation . Nucleic Acids Res . 2022 ; 50 : D340‑d346 . 41 . Youn JY , Dyakov BJA , Zhang J , Knight JDR , Vernon RM , Forman‑Kay JD , Gingras AC . Properties of stress granule and P‑body proteomes . Mol Cell . 2019 ; 76 : 286 – 94 . 42 . Navarro AM , Orti F , Martínez‑Pérez E , Alonso M , Simonetti FL , Iserte JA , Marino‑Buslje C . DisPhaseDB : an integrative database of diseases related variations in liquid‑liquid phase separation proteins . Comput Struct Biotechnol J . 2022 ; 20 : 2551 – 7 . 43 . Mészáros B , Erdos G , Dosztányi Z . IUPred2A : context‑dependent prediction of protein disorder as a function of redox state and protein binding . Nucleic Acids Res . 2018 ; 46 : W329‑w337 . Page 19 of 23 Zheng et al . Journal of Hematology & Oncology ( 2023 ) 16 : 123 44 . Xue B , Dunbrack RL , Williams RW , Dunker AK , Uversky VN . PONDR‑FIT : a meta‑predictor of intrinsically disordered amino acids . Biochim Biophys Acta . 1804 ; 2010 : 996 – 1010 . 45 . Piovesan D , Del Conte A , Clementel D , Monzon AM , Bevilacqua M , Aspromonte MC , Iserte JA , Orti FE , Marino‑Buslje C , Tosatto SCE . MobiDB : 10 years of intrinsically disordered proteins . Nucleic Acids Res . 2023 ; 51 : D438‑d444 . 46 . Holehouse AS , Das RK , Ahad JN , Richardson MO , Pappu RV . CIDER : resources to analyze sequence‑ensemble relationships of intrinsically disordered proteins . Biophys J . 2017 ; 112 : 16 – 21 . 47 . Thompson MJ , Sievers SA , Karanicolas J , Ivanova MI , Baker D , Eisenberg D . The 3D profile method for identifying fibril‑forming segments of proteins . Proc Natl Acad Sci U S A . 2006 ; 103 : 4074 – 8 . 48 . Kozlowski LP , Bujnicki JM . MetaDisorder : a meta‑server for the predic‑ tion of intrinsic disorder in proteins . BMC Bioinformatics . 2012 ; 13 : 111 . 49 . Huang YJ , Acton TB , Montelione GT . DisMeta : a meta server for con‑ struct design and optimization . Methods Mol Biol . 2014 ; 1091 : 3 – 16 . 50 . Duvaud S , Gabella C , Lisacek F , Stockinger H , Ioannidis V , Durinx C . Expasy , the Swiss bioinformatics resource portal , as designed by its users . Nucleic Acids Res . 2021 ; 49 : W216‑w227 . 51 . Nastou KC , Nasi GI , Tsiolaki PL , Litou ZI , Iconomidou VA . AmyCo : the amyloidoses collection . Amyloid . 2019 ; 26 : 112 – 7 . 52 . Mizianty MJ , Uversky V , Kurgan L . Prediction of intrinsic disorder in proteins using MFDp2 . Methods Mol Biol . 2014 ; 1137 : 147 – 62 . 53 . Case LB , Zhang X , Ditlev JA , Rosen MK . Stoichiometry controls activ‑ ity of phase‑separated clusters of actin signaling proteins . Science . 2019 ; 363 : 1093 – 7 . 54 . Li P , Banjade S , Cheng HC , Kim S , Chen B , Guo L , Llaguno M , Hollings‑ worth JV , King DS , Banani SF , Russo PS , Jiang QX , Nixon BT , Rosen MK . Phase transitions in the assembly of multivalent signalling proteins . Nature . 2012 ; 483 : 336 – 40 . 55 . Chong S , Dugast‑Darzacq C , Liu Z , Dong P , Dailey GM , Cattoglio C , Heckert A , Banala S , Lavis L , Darzacq X , Tjian R . Imaging dynamic and selective low‑complexity domain interactions that control gene tran‑ scription . Science . 2018 ; 361 : 2555 . 56 . Sanulli S , Trnka MJ , Dharmarajan V , Tibble RW , Pascal BD , Burlingame AL , Griffin PR , Gross JD , Narlikar GJ . HP1 reshapes nucleosome core to promote phase separation of heterochromatin . Nature . 2019 ; 575 : 390 – 4 . 57 . Xue B , Dunker AK , Uversky VN . Orderly order in protein intrinsic disorder distribution : disorder in 3500 proteomes from viruses and the three domains of life . J Biomol Struct Dyn . 2012 ; 30 : 137 – 49 . 58 . Oldfield CJ , Dunker AK . Intrinsically disordered proteins and intrinsically disordered protein regions . Annu Rev Biochem . 2014 ; 83 : 553 – 84 . 59 . Pessina F , Gioia U , Brandi O , Farina S , Ceccon M , Francia S , d’Adda di Fagagna F . DNA damage triggers a new phase in neurodegeneration . Trends Genet . 2021 ; 37 : 337 – 54 . 60 . Borcherds W , Bremer A , Borgia MB , Mittag T . How do intrinsically dis‑ ordered protein regions encode a driving force for liquid‑liquid phase separation ? Curr Opin Struct Biol . 2021 ; 67 : 41 – 50 . 61 . Lin Y , Currie SL , Rosen MK . Intrinsically disordered sequences enable modulation of protein phase separation through distributed tyrosine motifs . J Biol Chem . 2017 ; 292 : 19110 – 20 . 62 . Wang J , Choi JM , Holehouse AS , Lee HO , Zhang X , Jahnel M , Maharana S , Lemaitre R , Pozniakovsky A , Drechsel D , Poser I , Pappu RV , Alberti S , Hyman AA . A molecular grammar governing the driving forces for phase separation of prion‑like RNA binding proteins . Cell . 2018 ; 174 : 688‑ 699 . e616 . 63 . Hughes MP , Goldschmidt L , Eisenberg DS . Prevalence and species distri‑ bution of the low‑complexity , amyloid‑like , reversible , kinked segment structural motif in amyloid‑like fibrils . J Biol Chem . 2021 ; 297 : 101194 . 64 . Li J , Zhang Y , Chen X , Ma L , Li P , Yu H . Protein phase separation and its role in chromatin organization and diseases . Biomed Pharmacother . 2021 ; 138 : 111520 . 65 . Hughes MP , Sawaya MR , Boyer DR , Goldschmidt L , Rodriguez JA , Cascio D , Chong L , Gonen T , Eisenberg DS . Atomic structures of low‑complex‑ ity protein segments reveal kinked β sheets that assemble networks . Science . 2018 ; 359 : 698 – 701 . 66 . Barrio M , Huguet J , Robert B , Rietveld IB , Céolin R , Tamarit JL . Pressure‑ temperature phase diagram of the dimorphism of the anti‑inflamma‑ tory drug nimesulide . Int J Pharm . 2017 ; 525 : 54 – 9 . 67 . Yu M , Peng Z , Qin M , Liu Y , Wang J , Zhang C , Lin J , Dong T , Wang L , Li S , Yang Y , Xu S , Guo W , Zhang X , Shi M , Peng H , Luo X , Zhang H , Zhang L , Li Y , Yang XP , Sun S . Interferon‑γ induces tumor resistance to anti‑ PD‑1 immunotherapy by promoting YAP phase separation . Mol Cell . 2021 ; 81 : 1216‑1230 . e1219 . 68 . Lu Y , Wu T , Gutman O , Lu H , Zhou Q , Henis YI , Luo K . Phase separation of TAZ compartmentalizes the transcription machinery to promote gene expression . Nat Cell Biol . 2020 ; 22 : 453 – 64 . 69 . Conicella AE , Zerze GH , Mittal J , Fawzi NL . ALS mutations disrupt phase separation mediated by α‑helical structure in the TDP‑43 low‑complex‑ ity C‑terminal domain . Structure . 2016 ; 24 : 1537 – 49 . 70 . Lin Y , Fichou Y , Longhini AP , Llanes LC , Yin P , Bazan GC , Kosik KS , Han S . Liquid‑liquid phase separation of tau driven by hydrophobic interaction facilitates fibrillization of tau . J Mol Biol . 2021 ; 433 : 166731 . 71 . Vieregg JR , Lueckheide M , Marciel AB , Leon L , Bologna AJ , Rivera JR , Tirrell MV . Oligonucleotide‑peptide complexes : phase control by hybridization . J Am Chem Soc . 2018 ; 140 : 1632 – 8 . 72 . Jain A , Vale RD . RNA phase transitions in repeat expansion disorders . Nature . 2017 ; 546 : 243 – 7 . 73 . Baudin A , Moreno‑Romero AK , Xu X , Selig EE , Penalva LOF , Libich DS . Structural characterization of the RNA‑binding protein SERBP1 reveals intrinsic disorder and atypical RNA binding modes . Front Mol Biosci . 2021 ; 8 : 744707 . 74 . Ries RJ , Zaccara S , Klein P , Olarerin‑George A , Namkoong S , Pickering BF , Patil DP , Kwak H , Lee JH , Jaffrey SR . m ( 6 ) A enhances the phase separa‑ tion potential of mRNA . Nature . 2019 ; 571 : 424 – 8 . 75 . Kato M , Han TW , Xie S , Shi K , Du X , Wu LC , Mirzaei H , Goldsmith EJ , Longgood J , Pei J , Grishin NV , Frantz DE , Schneider JW , Chen S , Li L , Sawaya MR , Eisenberg D , Tycko R , McKnight SL . Cell‑free formation of RNA granules : low complexity sequence domains form dynamic fibers within hydrogels . Cell . 2012 ; 149 : 753 – 67 . 76 . Fox AH , Nakagawa S , Hirose T , Bond CS . Paraspeckles : where long noncoding RNA meets phase separation . Trends Biochem Sci . 2018 ; 43 : 124 – 35 . 77 . Lan Q , Liu PY , Haase J , Bell JL , Hüttelmaier S , Liu T . The critical role of RNA m ( 6 ) A methylation in cancer . Cancer Res . 2019 ; 79 : 1285 – 92 . 78 . Bienz M . Head‑to‑tail polymerization in the assembly of biomolecular condensates . Cell . 2020 ; 182 : 799 – 811 . 79 . Bienz M . Signalosome assembly by domains undergoing dynamic head‑to‑tail polymerization . Trends Biochem Sci . 2014 ; 39 : 487 – 95 . 80 . Schwarz‑Romond T , Merrifield C , Nichols BJ , Bienz M . The Wnt signalling effector Dishevelled forms dynamic protein assemblies rather than sta‑ ble associations with cytoplasmic vesicles . J Cell Sci . 2005 ; 118 : 5269 – 77 . 81 . Gammons M , Bienz M . Multiprotein complexes governing Wnt signal transduction . Curr Opin Cell Biol . 2018 ; 51 : 42 – 9 . 82 . Huang SM , Mishina YM , Liu S , Cheung A , Stegmeier F , Michaud GA , Charlat O , Wiellette E , Zhang Y , Wiessner S , Hild M , Shi X , Wilson CJ , Mickanin C , Myer V , Fazal A , Tomlinson R , Serluca F , Shao W , Cheng H , Shultz M , Rau C , Schirle M , Schlegl J , Ghidelli S , Fawell S , Lu C , Curtis D , Kirschner MW , Lengauer C , Finan PM , Tallarico JA , Bouwmeester T , Porter JA , Bauer A , Cong F . Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling . Nature . 2009 ; 461 : 614 – 20 . 83 . Chandra B , Michmerhuizen NL , Shirnekhi HK , Tripathi S , Pioso BJ , Baggett DW , Mitrea DM , Iacobucci I , White MR , Chen J , Park CG , Wu H , Pounds S , Medyukhina A , Khairy K , Gao Q , Qu C , Abdelhamed S , Gorman SD , Bawa S , Maslanka C , Kinger S , Dogra P , Ferrolino MC , Di Giacomo D , Mecucci C , Klco JM , Mullighan CG , Kriwacki RW . Phase separation mediates NUP98 fusion oncoprotein leukemic transforma‑ tion . Cancer Discov . 2022 ; 12 : 1152 – 69 . 84 . Qin Z , Sun H , Yue M , Pan X , Chen L , Feng X , Yan X , Zhu X , Ji H . Phase separation of EML4‑ALK in firing downstream signaling and promoting lung tumorigenesis . Cell Discov . 2021 ; 7 : 33 . 85 . Fawal M , Espinos E , Jean‑Jean O , Morello D . Looking for the functions of RNA granules in ALK‑transformed cells . BioArchitecture . 2011 ; 1 : 91 – 5 . 86 . Weatheritt RJ , Luck K , Petsalaki E , Davey NE , Gibson TJ . The identification of short linear motif‑mediated interfaces within the human interac‑ tome . Bioinformatics . 2012 ; 28 : 976 – 82 . 87 . Tompa P , Fuxreiter M , Oldfield CJ , Simon I , Dunker AK , Uversky VN . Close encounters of the third kind : disordered domains and the interactions of proteins . BioEssays . 2009 ; 31 : 328 – 35 . Page 20 of 23 Zheng et al . Journal of Hematology & Oncology ( 2023 ) 16 : 123 88 . Xiang S , Kato M , Wu LC , Lin Y , Ding M , Zhang Y , Yu Y , McKnight SL . The LC domain of hnRNPA2 adopts similar conformations in hydrogel polymers , liquid‑like droplets , and nuclei . Cell . 2015 ; 163 : 829 – 39 . 89 . Hancock R . A role for macromolecular crowding effects in the assembly and function of compartments in the nucleus . J Struct Biol . 2004 ; 146 : 281 – 90 . 90 . Weber SC , Brangwynne CP . Inverse size scaling of the nucleolus by a concentration‑dependent phase transition . Curr Biol . 2015 ; 25 : 641 – 6 . 91 . Franzmann TM , Jahnel M , Pozniakovsky A , Mahamid J , Holehouse AS , Nüske E , Richter D , Baumeister W , Grill SW , Pappu RV , Hyman AA , Alberti S . Phase separation of a yeast prion protein promotes cellular fitness . Science . 2018 ; 359 : 5654 . 92 . Wang Y , Annunziata O . Comparison between protein‑polyethylene glycol ( PEG ) interactions and the effect of PEG on protein‑protein interactions using the liquid‑liquid phase transition . J Phys Chem B . 2007 ; 111 : 1222 – 30 . 93 . Alberti S , Gladfelter A , Mittag T . Considerations and challenges in study‑ ing liquid‑liquid phase separation and biomolecular condensates . Cell . 2019 ; 176 : 419 – 34 . 94 . Yamaguchi A , Kitajo K . The effect of PRMT1‑mediated arginine methyla‑ tion on the subcellular localization , stress granules , and detergent‑ insoluble aggregates of FUS / TLS . PLoS ONE . 2012 ; 7 : e49267 . 95 . Gal J , Zhang J , Kwinter DM , Zhai J , Jia H , Jia J , Zhu H . Nuclear localization sequence of FUS and induction of stress granules by ALS mutants . Neurobiol Aging . 2011 ; 32 ( 2323 ) : e2327‑2340 . 96 . Hofweber M , Dormann D . Friend or foe‑Post‑translational modifications as regulators of phase separation and RNP granule dynamics . J Biol Chem . 2019 ; 294 : 7137 – 50 . 97 . Tanikawa C , Ueda K , Suzuki A , Iida A , Nakamura R , Atsuta N , Tohnai G , Sobue G , Saichi N , Momozawa Y , Kamatani Y , Kubo M , Yamamoto K , Nakamura Y , Matsuda K . Citrullination of RGG motifs in FET proteins by PAD4 regulates protein aggregation and ALS susceptibility . Cell Rep . 2018 ; 22 : 1473 – 83 . 98 . Bah A , Forman‑Kay JD . Modulation of intrinsically disordered protein function by post‑translational modifications . J Biol Chem . 2016 ; 291 : 6696 – 705 . 99 . Banani SF , Rice AM , Peeples WB , Lin Y , Jain S , Parker R , Rosen MK . Compositional control of phase‑separated cellular bodies . Cell . 2016 ; 166 : 651 – 63 . 100 . Hendriks IA , Lyon D , Young C , Jensen LJ , Vertegaal AC , Nielsen ML . Site‑ specific mapping of the human SUMO proteome reveals co‑modifica‑ tion with phosphorylation . Nat Struct Mol Biol . 2017 ; 24 : 325 – 36 . 101 . Ishov AM , Sotnikov AG , Negorev D , Vladimirova OV , Neff N , Kamitani T , Yeh ET , Strauss JF 3rd , Maul GG . PML is critical for ND10 formation and recruits the PML‑interacting protein daxx to this nuclear structure when modified by SUMO‑1 . J Cell Biol . 1999 ; 147 : 221 – 34 . 102 . Nott TJ , Petsalaki E , Farber P , Jervis D , Fussner E , Plochowietz A , Craggs TD , Bazett‑Jones DP , Pawson T , Forman‑Kay JD , Baldwin AJ . Phase transition of a disordered nuage protein generates environmentally responsive membraneless organelles . Mol Cell . 2015 ; 57 : 936 – 47 . 103 . Xia Q , Li Y , Xu W , Wu C , Zheng H , Liu L , Dong L . Enhanced liquidity of p62 droplets mediated by Smurf1 links Nrf2 activation and autophagy . Cell Biosci . 2023 ; 13 : 37 . 104 . Bouchard JJ , Otero JH , Scott DC , Szulc E , Martin EW , Sabri N , Granata D , Marzahn MR , Lindorff‑Larsen K , Salvatella X , Schulman BA , Mittag T . Cancer mutations of the tumor suppressor SPOP disrupt the formation of active , phase‑separated compartments . Mol Cell . 2018 ; 72 : 19‑36 . e18 . 105 . Cheng Y , Xie W , Pickering BF , Chu KL , Savino AM , Yang X , Luo H , Nguyen DT , Mo S , Barin E , Velleca A , Rohwetter TM , Patel DJ , Jaffrey SR , Kharas MG . N ( 6 ) ‑Methyladenosine on mRNA facilitates a phase‑separated nuclear body that suppresses myeloid leukemic differentiation . Cancer Cell . 2021 ; 39 : 958‑972 . e958 . 106 . Shi B , Li W , Song Y , Wang Z , Ju R , Ulman A , Hu J , Palomba F , Zhao Y , Le JP , Jarrard W , Dimoff D , Digman MA , Gratton E , Zang C , Jiang H . UTX condensation underlies its tumour‑suppressive activity . Nature . 2021 ; 597 : 726 – 31 . 107 . Wei M , Huang X , Liao L , Tian Y , Zheng X . SENP1 decreases RNF168 phase separation to promote DNA damage repair and drug resistance in colon cancer . Cancer Res . 2023 ; 83 ( 17 ) : 2908 – 23 . 108 . Wu Y , Zhou L , Zou Y , Zhang Y , Zhang M , Xu L , Zheng L , He W , Yu K , Li T , Zhang X , Chen Z , Zhang R , Zhou P , Zhang N , Zheng L , Kang T . Disrupting the phase separation of KAT8‑IRF1 diminishes PD‑L1 expres‑ sion and promotes antitumor immunity . Nat Cancer . 2023 ; 4 : 382 – 400 . 109 . Shao X , Chen Y , Xu A , Xiang D , Wang W , Du W , Huang Y , Zhang X , Cai M , Xia Z , Wang Y , Cao J , Zhang Y , Yang B , He Q , Ying M . Deneddylation of PML / RARα reconstructs functional PML nuclear bodies via orchestrating phase separation to eradicate APL . Cell Death Differ . 2022 ; 29 : 1654 – 68 . 110 . Martinelli E , Morgillo F , Troiani T , Ciardiello F . Cancer resistance to thera‑ pies against the EGFR‑RAS‑RAF pathway : the role of MEK . Cancer Treat Rev . 2017 ; 53 : 61 – 9 . 111 . Liang SI , van Lengerich B , Eichel K , Cha M , Patterson DM , Yoon TY , von Zastrow M , Jura N , Gartner ZJ . Phosphorylated EGFR dimers are not sufficient to activate ras . Cell Rep . 2018 ; 22 : 2593 – 600 . 112 . Grabarz A , Barascu A , Guirouilh‑Barbat J , Lopez BS . Initiation of DNA double strand break repair : signaling and single‑stranded resection dictate the choice between homologous recombination , non‑ homologous end‑joining and alternative end‑joining . Am J Cancer Res . 2012 ; 2 : 249 – 68 . 113 . Zhang J , Zeng Y , Xing Y , Li X , Zhou L , Hu L , Chin YE , Wu M . Myristoyla‑ tion‑mediated phase separation of EZH2 compartmentalizes STAT3 to promote lung cancer growth . Cancer Lett . 2021 ; 516 : 84 – 98 . 114 . Lanz MC , Dibitetto D , Smolka MB . DNA damage kinase signaling : check‑ point and repair at 30 years . Embo j . 2019 ; 38 : e101801 . 115 . Li W , Shu X , Zhang X , Zhang Z , Sun S , Li N , Long M . Potential Roles of YAP / TAZ mechanotransduction in spaceflight‑induced liver dysfunc‑ tion . Int J Mol Sci . 2023 ; 24 ( 3 ) : 2197 . 116 . Liu Q , Li J , Zhang W , Xiao C , Zhang S , Nian C , Li J , Su D , Chen L , Zhao Q , Shao H , Zhao H , Chen Q , Li Y , Geng J , Hong L , Lin S , Wu Q , Deng X , Ke R , Ding J , Johnson RL , Liu X , Chen L , Zhou D . Glycogen accumulation and phase separation drives liver tumor initiation . Cell . 2021 ; 184 : 5559‑5576 . e5519 . 117 . Zhu G , Xie J , Fu Z , Wang M , Zhang Q , He H , Chen Z , Guo X , Zhu J . Pharmacological inhibition of SRC‑1 phase separation suppresses YAP oncogenic transcription activity . Cell Res . 2021 ; 31 : 1028 – 31 . 118 . Kamagata K , Kanbayashi S , Honda M , Itoh Y , Takahashi H , Kameda T , Nagatsugi F , Takahashi S . Liquid‑like droplet formation by tumor sup‑ pressor p53 induced by multivalent electrostatic interactions between two disordered domains . Sci Rep . 2020 ; 10 : 580 . 119 . Kilic S , Lezaja A , Gatti M , Bianco E , Michelena J , Imhof R , Altmeyer M . Phase separation of 53BP1 determines liquid‑like behavior of DNA repair compartments . Embo j . 2019 ; 38 : e101379 . 120 . Esposito M , Fang C , Cook KC , Park N , Wei Y , Spadazzi C , Bracha D , Gunaratna RT , Laevsky G , DeCoste CJ , Slabodkin H , Brangwynne CP , Cristea IM , Kang Y . TGF‑β‑induced DACT1 biomolecular condensates repress Wnt signalling to promote bone metastasis . Nat Cell Biol . 2021 ; 23 : 257 – 67 . 121 . Zamudio AV , Dall’Agnese A , Henninger JE , Manteiga JC , Afeyan LK , Hannett NM , Coffey EL , Li CH , Oksuz O , Sabari BR , Boija A , Klein IA , Hawken SW , Spille JH , Decker TM , Cisse BJ II , Abraham TI , Lee DJ , Taatjes J , Schuijers RA . Young , mediator condensates localize signaling factors to key cell identity genes . Mol Cell . 2019 ; 76 : 753 – 66 . 122 . Zhang JZ , Lu TW , Stolerman LM , Tenner B , Yang JR , Zhang JF , Falcke M , Rangamani P , Taylor SS , Mehta S , Zhang J . Phase Separation of a PKA regulatory subunit controls camp compartmentation and oncogenic signaling . Cell . 2020 ; 182 : 1531‑1544 . e1515 . 123 . Tulpule A , Guan J , Neel DS , Allegakoen HR , Lin YP , Brown D , Chou YT , Heslin A , Chatterjee N , Perati S , Menon S , Nguyen TA , Debnath J , Ramirez AD , Shi X , Yang B , Feng S , Makhija S , Huang B , Bivona TG . Kinase‑mediated RAS signaling via membraneless cytoplasmic protein granules . Cell . 2021 ; 184 : 2649‑2664 . e2618 . 124 . Sampson J , Richards MW , Choi J , Fry AM , Bayliss R . Phase‑separated foci of EML4‑ALK facilitate signalling and depend upon an active kinase conformation . EMBO Rep . 2021 ; 22 : e53693 . 125 . Huang WYC , Alvarez S , Kondo Y , Lee YK , Chung JK , Lam HYM , Biswas KH , Kuriyan J , Groves JT . A molecular assembly phase transition and kinetic proofreading modulate Ras activation by SOS . Science . 2019 ; 363 : 1098 – 103 . 126 . Zhu G , Xie J , Kong W , Xie J , Li Y , Du L , Zheng Q , Sun L , Guan M , Li H , Zhu T , He H , Liu Z , Xia X , Kan C , Tao Y , Shen HC , Li D , Wang S , Yu Y , Yu ZH , Zhang ZY , Liu C , Zhu J . Phase separation of disease‑associated SHP2 mutants underlies MAPK hyperactivation . Cell . 2020 ; 183 : 490‑502 . e418 . Page 21 of 23 Zheng et al . Journal of Hematology & Oncology ( 2023 ) 16 : 123 127 . Schaefer KN , Peifer M . Wnt / beta‑catenin signaling regulation and a role for biomolecular condensates . Dev Cell . 2019 ; 48 : 429 – 44 . 128 . Cloer EW , Siesser PF , Cousins EM , Goldfarb D , Mowrey DD , Harrison JS , Weir SJ , Dokholyan NV , Major MB . p62‑Dependent Phase Separa‑ tion of Patient‑Derived KEAP1 Mutations and NRF2 . Mol Cell Biol . 2018 ; 38 ( 22 ) : 00644 – 717 . 129 . Jobe F , Simpson J , Hawes P , Guzman E , Bailey D . Respiratory syncytial virus sequesters NF‑κB subunit p65 to cytoplasmic inclusion bodies to inhibit innate immune signaling . J Virol . 2020 ; 94 ( 22 ) : 10 – 1128 . 130 . Meng F , Yu Z , Zhang D , Chen S , Guan H , Zhou R , Wu Q , Zhang Q , Liu S , Venkat Ramani MK , Yang B , Ba XQ , Zhang J , Huang J , Bai X , Qin J , Feng XH , Ouyang S , Zhang YJ , Liang T , Xu P . Induced phase separation of mutant NF2 imprisons the cGAS‑STING machinery to abrogate antitu‑ mor immunity . Mol Cell . 2021 ; 81 : 4147 – 64 . 131 . Todoric J , Antonucci L , Di Caro G , Li N , Wu X , Lytle NK , Dhar D , Banerjee S , Fagman JB , Browne CD , Umemura A , Valasek MA , Kessler H , Tarin D , Goggins M , Reya T , Diaz‑Meco M , Moscat J , Karin M . Stress‑activated NRF2‑MDM2 cascade controls neoplastic progression in pancreas . Cancer Cell . 2017 ; 32 : 824‑839 . e828 . 132 . Wang S , Zhang Q , Wang Q , Shen Q , Chen X , Li Z , Zhou Y , Hou J , Xu B , Li N , Cao X . NEAT1 paraspeckle promotes human hepatocellular carcinoma progression by strengthening IL‑6 / STAT3 signaling . Oncoim‑ munology . 2018 ; 7 : e1503913 . 133 . Taub R , Kirsch I , Morton C , Lenoir G , Swan D , Tronick S , Aaronson S , Leder P . Translocation of the c‑myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacy‑ toma cells . Proc Natl Acad Sci U S A . 1982 ; 79 : 7837 – 41 . 134 . Dalla‑Favera R , Martinotti S , Gallo RC , Erikson J , Croce CM . Translocation and rearrangements of the c‑myc oncogene locus in human undif‑ ferentiated B‑cell lymphomas . Science . 1983 ; 219 : 963 – 7 . 135 . Tabin CJ , Bradley SM , Bargmann CI , Weinberg RA , Papageorge AG , Scolnick EM , Dhar R , Lowy DR , Chang EH . Mechanism of activation of a human oncogene . Nature . 1982 ; 300 : 143 – 9 . 136 . Weinstein IB , Joe A . Oncogene addiction . Cancer Res . 2008 ; 68 : 3077 – 80 . 137 . Su X , Ditlev JA , Hui E , Xing W , Banjade S , Okrut J , King DS , Taunton J , Rosen MK , Vale RD . Phase separation of signaling molecules promotes T cell receptor signal transduction . Science . 2016 ; 352 : 595 – 9 . 138 . Huang WY , Yan Q , Lin WC , Chung JK , Hansen SD , Christensen SM , Tu HL , Kuriyan J , Groves JT . Phosphotyrosine‑mediated LAT assembly on membranes drives kinetic bifurcation in recruitment dynamics of the Ras activator SOS . Proc Natl Acad Sci U S A . 2016 ; 113 : 8218 – 23 . 139 . Yamazaki T , Zaal K , Hailey D , Presley J , Lippincott‑Schwartz J , Samelson LE . Role of Grb2 in EGF‑stimulated EGFR internalization . J Cell Sci . 2002 ; 115 : 1791 – 802 . 140 . Lamouille S , Xu J , Derynck R . Molecular mechanisms of epithelial‑mes‑ enchymal transition . Nat Rev Mol Cell Biol . 2014 ; 15 : 178 – 96 . 141 . Cordenonsi M , Zanconato F , Azzolin L , Forcato M , Rosato A , Frasson C , Inui M , Montagner M , Parenti AR , Poletti A , Daidone MG , Dupont S , Basso G , Bicciato S , Piccolo S . The Hippo transducer TAZ confers cancer stem cell‑related traits on breast cancer cells . Cell . 2011 ; 147 : 759 – 72 . 142 . Zanconato F , Cordenonsi M , Piccolo S . YAP / TAZ at the Roots of Cancer . Cancer Cell . 2016 ; 29 : 783 – 803 . 143 . Gao H , Wei H , Yang Y , Li H , Liang J , Ye J , Zhang F , Wang L , Shi H , Wang J , Han A . Phase separation of DDX21 promotes colorectal cancer metasta‑ sis via MCM5‑dependent EMT pathway . Oncogene . 2023 ; 42 : 1704 – 15 . 144 . Wang Y , Fu D , Chen Y , Su J , Wang Y , Li X , Zhai W , Niu Y , Yue D , Geng H . G3BP1 promotes tumor progression and metastasis through IL‑6 / G3BP1 / STAT3 signaling axis in renal cell carcinomas . Cell Death Dis . 2018 ; 9 : 501 . 145 . Taniuchi K , Nishimori I , Hollingsworth MA . The N‑terminal domain of G3BP enhances cell motility and invasion by posttranscriptional regula‑ tion of BART . Mol Cancer Res . 2011 ; 9 : 856 – 66 . 146 . Clark A , Burleson M . SPOP and cancer : a systematic review . Am J Cancer Res . 2020 ; 10 : 704 – 26 . 147 . Ghodke I , Remisova M , Furst A , Kilic S , Reina‑San‑Martin B , Poetsch AR , Altmeyer M , Soutoglou E . AHNAK controls 53BP1‑mediated p53 response by restraining 53BP1 oligomerization and phase separation . Mol Cell . 2021 ; 81 : 2596‑2610 . e2597 . 148 . Massagué J . TGFbeta in Cancer . Cell . 2008 ; 134 : 215 – 30 . 149 . Rangel LP , Costa DC , Vieira TC , Silva JL . The aggregation of mutant p53 produces prion‑like properties in cancer . Prion . 2014 ; 8 : 75 – 84 . 150 . Ano Bom AP , Rangel LP , Costa DC , de Oliveira GA , Sanches D , Braga CA , Gava LM , Ramos CH , Cepeda AO , Stumbo AC , De Moura Gallo CV , Cord‑ eiro Y , Silva JL . Mutant p53 aggregates into prion‑like amyloid oligomers and fibrils : implications for cancer . J Biol Chem . 2012 ; 287 : 28152 – 62 . 151 . Xu J , Reumers J , Couceiro JR , De Smet F , Gallardo R , Rudyak S , Cornelis A , Rozenski J , Zwolinska A , Marine JC , Lambrechts D , Suh YA , Rousseau F , Schymkowitz J . Gain of function of mutant p53 by coaggregation with multiple tumor suppressors . Nat Chem Biol . 2011 ; 7 : 285 – 95 . 152 . Higashimoto Y , Asanomi Y , Takakusagi S , Lewis MS , Uosaki K , Durell SR , Anderson CW , Appella E , Sakaguchi K . Unfolding , aggregation , and amyloid formation by the tetramerization domain from mutant p53 associated with lung cancer . Biochemistry . 2006 ; 45 : 1608 – 19 . 153 . Ishimaru D , Andrade LR , Teixeira LS , Quesado PA , Maiolino LM , Lopez PM , Cordeiro Y , Costa LT , Heckl WM , Weissmüller G , Foguel D , Silva JL . Fibrillar aggregates of the tumor suppressor p53 core domain . Bio‑ chemistry . 2003 ; 42 : 9022 – 7 . 154 . De Smet F , Saiz Rubio M , Hompes D , Naus E , De Baets G , Langenberg T , Hipp MS , Houben B , Claes F , Charbonneau S , Delgado Blanco J , Plai‑ sance S , Ramkissoon S , Ramkissoon L , Simons C , van den Brandt P , Wei‑ jenberg M , Van England M , Lambrechts S , Amant F , D’Hoore A , Ligon KL , Sagaert X , Schymkowitz J , Rousseau F . Nuclear inclusion bodies of mutant and wild‑type p53 in cancer : a hallmark of p53 inactivation and proteostasis remodelling by p53 aggregation . J Pathol . 2017 ; 242 : 24 – 38 . 155 . Oda T , Gotoh N , Kasamatsu T , Handa H , Saitoh T , Sasaki N . DNA damage‑ induced cellular senescence is regulated by 53BP1 accumulation in the nuclear foci and phase separation . Cell Prolif . 2023 ; 56 : e13398 . 156 . Hayflick L . The limited in vitro lifetime of human diploid cell strains . Exp Cell Res . 1965 ; 37 : 614 – 36 . 157 . Blackburn EH . Structure and function of telomeres . Nature . 1991 ; 350 : 569 – 73 . 158 . Greider CW . Telomere length regulation . Annu Rev Biochem . 1996 ; 65 : 337 – 65 . 159 . Zhang H , Zhao R , Tones J , Liu M , Dilley RL , Chenoweth DM , Greenberg RA , Lampson MA . Nuclear body phase separation drives telomere clustering in ALT cancer cells . Mol Biol Cell . 2020 ; 31 : 2048 – 56 . 160 . Min J , Wright WE , Shay JW . Clustered telomeres in phase‑separated nuclear condensates engage mitotic DNA synthesis through BLM and RAD52 . Genes Dev . 2019 ; 33 : 814 – 27 . 161 . Larson AG , Elnatan D , Keenen MM , Trnka MJ , Johnston JB , Burlingame AL , Agard DA , Redding S , Narlikar GJ . Liquid droplet formation by HP1α suggests a role for phase separation in heterochromatin . Nature . 2017 ; 547 : 236 – 40 . 162 . Wang L , Gao Y , Zheng X , Liu C , Dong S , Li R , Zhang G , Wei Y , Qu H , Li Y , Allis CD , Li G , Li H , Li P . Histone modifications regulate chromatin com‑ partmentalization by contributing to a phase separation mechanism . Mol Cell . 2019 ; 76 : 646‑659 . e646 . 163 . Ma S , Chen C , Ji X , Liu J , Zhou Q , Wang G , Yuan W , Kan Q , Sun Z . The interplay between m6A RNA methylation and noncoding RNA in cancer . J Hematol Oncol . 2019 ; 12 : 121 . 164 . Gao Y , Pei G , Li D , Li R , Shao Y , Zhang QC , Li P . Multivalent m ( 6 ) A motifs promote phase separation of YTHDF proteins . Cell Res . 2019 ; 29 : 767 – 9 . 165 . Woo SR , Fuertes MB , Corrales L , Spranger S , Furdyna MJ , Leung MY , Duggan R , Wang Y , Barber GN , Fitzgerald KA , Alegre ML , Gajewski TF . STING‑dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors . Immunity . 2014 ; 41 : 830 – 42 . 166 . Deng L , Liang H , Xu M , Yang X , Burnette B , Arina A , Li XD , Mauceri H , Beckett M , Darga T , Huang X , Gajewski TF , Chen ZJ , Fu YX , Weich‑ selbaum RR . STING‑dependent cytosolic DNA sensing promotes radiation‑induced type I interferon‑dependent antitumor immunity in immunogenic tumors . Immunity . 2014 ; 41 : 843 – 52 . 167 . Marcus A , Mao AJ , Lensink‑Vasan M , Wang L , Vance RE , Raulet DH . Tumor‑derived cGAMP triggers a STING‑mediated interferon response in non‑tumor cells to activate the nk cell response . Immunity . 2018 ; 49 : 754‑763 . e754 . 168 . Grivennikov SI , Greten FR , Karin M . Immunity , inflammation , and cancer . Cell . 2010 ; 140 : 883 – 99 . 169 . Vladimirova O , De Leo A , Deng Z , Wiedmer A , Hayden J , Lieberman PM . Phase separation and DAXX redistribution contribute to LANA nuclear body and KSHV genome dynamics during latency and reactivation . PLoS Pathog . 2021 ; 17 : e1009231 . Page 22 of 23 Zheng et al . Journal of Hematology & Oncology ( 2023 ) 16 : 123 170 . Peng Q , Wang L , Qin Z , Wang J , Zheng X , Wei L , Zhang X , Zhang X , Liu C , Li Z , Wu Y , Li G , Yan Q , Ma J . Phase separation of epstein‑barr virus EBNA2 and its coactivator EBNALP controls gene expression . J Virol . 2020 ; 94 ( 7 ) : 10 – 1128 . 171 . Peng Q , Wang L , Wang J , Liu C , Zheng X , Zhang X , Wei L , Li Z , Wu Y , Wen Y , Cao P , Liao Q , Yan Q , Ma J . Epstein‑Barr virus EBNA2 phase separation regulates cancer‑associated alternative RNA splicing patterns . Clin Transl Med . 2021 ; 11 : e504 . 172 . Baudino TA , McKay C , Pendeville‑Samain H , Nilsson JA , Maclean KH , White EL , Davis AC , Ihle JN , Cleveland JL . c‑Myc is essential for vasculo‑ genesis and angiogenesis during development and tumor progression . Genes Dev . 2002 ; 16 : 2530 – 43 . 173 . Jiang Y , Lei G , Lin T , Zhou N , Wu J , Wang Z , Fan Y , Sheng H , Mao R . 1 , 6‑Hexanediol regulates angiogenesis via suppression of cyclin A1‑mediated endothelial function . BMC Biol . 2023 ; 21 : 75 . 174 . Shi Y , Liao Y , Liu Q , Ni Z , Zhang Z , Shi M , Li P , Li H , Rao Y . BRD4‑targeting PROTAC as a unique tool to study biomolecular condensates . Cell Discov . 2023 ; 9 : 47 . 175 . Cai D , Liu Z , Lippincott‑Schwartz J . Biomolecular condensates and their links to cancer progression . Trends Biochem Sci . 2021 ; 46 : 535 – 49 . 176 . Ma X , Liu Y , Liu Y , Alexandrov LB , Edmonson MN , Gawad C , Zhou X , Li Y , Rusch MC , Easton J , Huether R , Gonzalez‑Pena V , Wilkinson MR , Hermida LC , Davis S , Sioson E , Pounds S , Cao X , Ries RE , Wang Z , Chen X , Dong L , Diskin SJ , Smith MA , Guidry Auvil JM , Meltzer PS , Lau CC , Perlman EJ , Maris JM , Meshinchi S , Hunger SP , Gerhard DS , Zhang J . Pan‑cancer genome and transcriptome analyses of 1699 paediatric leukaemias and solid tumours . Nature . 2018 ; 555 : 371 – 6 . 177 . Bolouri H , Farrar JE , Triche T Jr , Ries RE , Lim EL , Alonzo TA , Ma Y , Moore R , Mungall AJ , Marra MA , Zhang J , Ma X , Liu Y , Liu Y , Auvil JMG , Davidsen TM , Gesuwan P , Hermida LC , Salhia B , Capone S , Ramsingh G , Zwaan CM , Noort S , Piccolo SR , Kolb EA , Gamis AS , Smith MA , Gerhard DS , Meshinchi S . The molecular landscape of pediatric acute myeloid leuke‑ mia reveals recurrent structural alterations and age‑specific mutational interactions . Nat Med . 2018 ; 24 : 103 – 12 . 178 . Struski S , Lagarde S , Bories P , Puiseux C , Prade N , Cuccuini W , Pages MP , Bidet A , Gervais C , Lafage‑Pochitaloff M , Roche‑Lestienne C , Barin C , Penther D , Nadal N , Radford‑Weiss I , Collonge‑Rame MA , Gaillard B , Mugneret F , Lefebvre C , Bart‑Delabesse E , Petit A , Leverger G , Broccardo C , Luquet I , Pasquet M , Delabesse E . NUP98 is rearranged in 3 . 8 % of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis . Leukemia . 2017 ; 31 : 565 – 72 . 179 . McNeer NA , Philip J , Geiger H , Ries RE , Lavallée VP , Walsh M , Shah M , Arora K , Emde AK , Robine N , Alonzo TA , Kolb EA , Gamis AS , Smith M , Gerhard DS , Guidry‑Auvil J , Meshinchi S , Kentsis A . Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leuke‑ mia . Leukemia . 2019 ; 33 : 1934 – 43 . 180 . Kasper LH , Brindle PK , Schnabel CA , Pritchard CE , Cleary ML , van Deursen JM . CREB binding protein interacts with nucleoporin‑specific FG repeats that activate transcription and mediate NUP98‑HOXA9 oncogenicity . Mol Cell Biol . 1999 ; 19 : 764 – 76 . 181 . Wang GG , Cai L , Pasillas MP , Kamps MP . NUP98‑NSD1 links H3K36 meth‑ ylation to Hox‑A gene activation and leukaemogenesis . Nat Cell Biol . 2007 ; 9 : 804 – 12 . 182 . Somasekharan SP , El‑Naggar A , Leprivier G , Cheng H , Hajee S , Grunewald TG , Zhang F , Ng T , Delattre O , Evdokimova V , Wang Y , Gleave M , Sorensen PH . YB‑1 regulates stress granule formation and tumor progression by translationally activating G3BP1 . J Cell Biol . 2015 ; 208 : 913 – 29 . 183 . Oda Y , Sakamoto A , Shinohara N , Ohga T , Uchiumi T , Kohno K , Tsuney‑ oshi M , Kuwano M , Iwamoto Y . Nuclear expression of YB‑1 protein correlates with P‑glycoprotein expression in human osteosarcoma . Clin Cancer Res . 1998 ; 4 : 2273 – 7 . 184 . Oda Y , Kohashi K , Yamamoto H , Tamiya S , Kohno K , Kuwano M , Iwamoto Y , Tajiri T , Taguchi T , Tsuneyoshi M . Different expression profiles of Y‑box‑binding protein‑1 and multidrug resistance‑associated proteins between alveolar and embryonal rhabdomyosarcoma . Cancer Sci . 2008 ; 99 : 726 – 32 . 185 . Fujiwara‑Okada Y , Matsumoto Y , Fukushi J , Setsu N , Matsuura S , Kamura S , Fujiwara T , Iida K , Hatano M , Nabeshima A , Yamada H , Ono M , Oda Y , Iwamoto Y . Y‑box binding protein‑1 regulates cell proliferation and is associated with clinical outcomes of osteosarcoma . Br J Cancer . 2013 ; 108 : 836 – 47 . 186 . Somasekharan SP , Saxena N , Zhang F , Beraldi E , Huang JN , Gentle C , Fazli L , Thi M , Sorensen PH , Gleave M . Regulation of AR mRNA transla‑ tion in response to acute AR pathway inhibition . Nucleic Acids Res . 2022 ; 50 : 1069 – 91 . 187 . Carmona‑Fontaine C , Deforet M , Akkari L , Thompson CB , Joyce JA , Xavier JB . Metabolic origins of spatial organization in the tumor micro‑ environment . Proc Natl Acad Sci U S A . 2017 ; 114 : 2934 – 9 . 188 . Tajan M , Hock AK , Blagih J , Robertson NA , Labuschagne CF , Kruiswijk F , Humpton TJ , Adams PD , Vousden KH . A role for p53 in the adaptation to glutamine starvation through the expression of SLC1A3 . Cell Metab . 2018 ; 28 : 721‑736 . e726 . 189 . Yuneva M , Zamboni N , Oefner P , Sachidanandam R , Lazebnik Y . Deficiency in glutamine but not glucose induces MYC‑dependent apoptosis in human cells . J Cell Biol . 2007 ; 178 : 93 – 105 . 190 . Rubin H . Deprivation of glutamine in cell culture reveals its potential for treating cancer . Proc Natl Acad Sci U S A . 2019 ; 116 : 6964 – 8 . 191 . Wang R , Cao L , Thorne RF , Zhang XD , Li J , Shao F , Zhang L , Wu M . LncRNA GIRGL drives CAPRIN1‑mediated phase separation to sup‑ press glutaminase‑1 translation under glutamine deprivation . Sci Adv . 2021 ; 7 : eabe5708 . 192 . Dixon SJ , Lemberg KM , Lamprecht MR , Skouta R , Zaitsev EM , Gleason CE , Patel DN , Bauer AJ , Cantley AM , Yang WS , Morrison B 3rd , Stockwell BR . Ferroptosis : an iron‑dependent form of nonapoptotic cell death . Cell . 2012 ; 149 : 1060 – 72 . 193 . Viswanathan VS , Ryan MJ , Dhruv HD , Gill S , Eichhoff OM , Seashore‑Lud‑ low B , Kaffenberger SD , Eaton JK , Shimada K , Aguirre AJ , Viswanathan SR , Chattopadhyay S , Tamayo P , Yang WS , Rees MG , Chen S , Boskovic ZV , Javaid S , Huang C , Wu X , Tseng YY , Roider EM , Gao D , Cleary JM , Wolpin BM , Mesirov JP , Haber DA , Engelman JA , Boehm JS , Kotz JD , Hon CS , Chen Y , Hahn WC , Levesque MP , Doench JG , Berens ME , Shamji AF , Clemons PA , Stockwell BR , Schreiber SL . Dependency of a therapy‑ resistant state of cancer cells on a lipid peroxidase pathway . Nature . 2017 ; 547 : 453 – 7 . 194 . Hangauer MJ , Viswanathan VS , Ryan MJ , Bole D , Eaton JK , Matov A , Galeas J , Dhruv HD , Berens ME , Schreiber SL , McCormick F , McManus MT . Drug‑tolerant persister cancer cells are vulnerable to GPX4 inhibi‑ tion . Nature . 2017 ; 551 : 247 – 50 . 195 . Nakamura T , Hipp C , Mourão ASD , Borggräfe J , Aldrovandi M , Henkel‑ mann B , Wanninger J , Mishima E , Lytton E , Emler D , Proneth B , Sattler M , Conrad M . Phase separation of FSP1 promotes ferroptosis . Nature . 2023 ; 619 : 371 – 7 . 196 . Berg T , Cohen SB , Desharnais J , Sonderegger C , Maslyar DJ , Goldberg J , Boger DL , Vogt PK . Small‑molecule antagonists of Myc / Max dimeriza‑ tion inhibit Myc‑induced transformation of chicken embryo fibroblasts . Proc Natl Acad Sci U S A . 2002 ; 99 : 3830 – 5 . 197 . Erkizan HV , Kong Y , Merchant M , Schlottmann S , Barber‑Rotenberg JS , Yuan L , Abaan OD , Chou TH , Dakshanamurthy S , Brown ML , Uren A , Toretsky JA . A small molecule blocking oncogenic protein EWS‑FLI1 interaction with RNA helicase A inhibits growth of Ewing’s sarcoma . Nat Med . 2009 ; 15 : 750 – 6 . 198 . Gupta N , Badeaux M , Liu Y , Naxerova K , Sgroi D , Munn LL , Jain RK , Garkavtsev I . Stress granule‑associated protein G3BP2 regulates breast tumor initiation . Proc Natl Acad Sci U S A . 2017 ; 114 : 1033 – 8 . 199 . Lemos C , Schulze L , Weiske J , Meyer H , Braeuer N , Barak N , Eberspächer U , Werbeck N , Stresemann C , Lange M , Lesche R , Zablowsky N , Juene‑ mann K , Kamburov A , Luh LM , Leissing TM , Mortier J , Steckel M , Steuber H , Eis K , Eheim A , Steigemann P . Identification of small molecules that modulate mutant p53 condensation . Science . 2020 ; 23 : 101517 . 200 . Mukherjee H , Chan KP , Andresen V , Hanley ML , Gjertsen BT , Myers AG . Interactions of the natural product ( + ) ‑avrainvillamide with nucleophosmin and exportin‑1 Mediate the cellular localization of nucleophosmin and its AML‑associated mutants . ACS Chem Biol . 2015 ; 10 : 855 – 63 . 201 . Chen YN , LaMarche MJ , Chan HM , Fekkes P , Garcia‑Fortanet J , Acker MG , Antonakos B , Chen CH , Chen Z , Cooke VG , Dobson JR , Deng Z , Fei F , Firestone B , Fodor M , Fridrich C , Gao H , Grunenfelder D , Hao HX , Jacob J , Ho S , Hsiao K , Kang ZB , Karki R , Kato M , Larrow J , La Bonte LR , Lenoir F , Liu G , Liu S , Majumdar D , Meyer MJ , Palermo M , Perez L , Pu Page 23 of 23 Zheng et al . Journal of Hematology & Oncology ( 2023 ) 16 : 123 • fast , convenient online submission • thorough peer review by experienced researchers in your ﬁeld • rapid publication on acceptance • support for research data , including large and complex data types • gold Open Access which fosters wider collaboration and increased citations maximum visibility for your research : over 100M website views per year • At BMC , research is always in progress . Learn more biomedcentral . com / submissions Ready to submit your research Ready to submit your research ? Choose BMC and benefit from : ? Choose BMC and benefit from : M , Price E , Quinn C , Shakya S , Shultz MD , Slisz J , Venkatesan K , Wang P , Warmuth M , Williams S , Yang G , Yuan J , Zhang JH , Zhu P , Ramsey T , Keen NJ , Sellers WR , Stams T , Fortin PD . Allosteric inhibition of SHP2 phos‑ phatase inhibits cancers driven by receptor tyrosine kinases . Nature . 2016 ; 535 : 148 – 52 . 202 . Klein IA , Boija A , Afeyan LK , Hawken SW , Fan M , Dall’Agnese A , Oksuz O , Henninger JE , Shrinivas K , Sabari BR , Sagi I , Clark VE , Platt JM , Kar M , McCall PM , Zamudio AV , Manteiga JC , Coffey EL , Li CH , Hannett NM , Guo YE , Decker TM , Lee TI , Zhang T , Weng JK , Taatjes DJ , Chakraborty A , Sharp PA , Chang YT , Hyman AA , Gray NS , Young RA . Partitioning of can‑ cer therapeutics in nuclear condensates . Science . 2020 ; 368 : 1386 – 92 . 203 . Zhang F , Biswas M , Massah S , Lee J , Lingadahalli S , Wong S , Wells C , Foo J , Khan N , Morin H , Saxena N , Kung SHY , Sun B , Parra Nuñez AK , Sanchez C , Chan N , Ung L , Altıntaş UB , Bui JM , Wang Y , Fazli L , Oo HZ , Rennie PS , Lack NA , Cherkasov A , Gleave ME , Gsponer J , Lallous N . Dynamic phase separation of the androgen receptor and its coactivators key to regulate gene expression . Nucleic Acids Res . 2023 ; 51 : 99 – 116 . 204 . Oka M , Mura S , Yamada K , Sangel P , Hirata S , Maehara K , Kawakami K , Tachibana T , Ohkawa Y , Kimura H , Yoneda Y . Chromatin‑prebound Crm1 recruits Nup98‑HoxA9 fusion to induce aberrant expression of Hox cluster genes . Elife . 2016 ; 5 : e09540 . 205 . Takayama KI , Kosaka T , Suzuki T , Hongo H , Oya M , Fujimura T , Suzuki Y , Inoue S . Subtype‑specific collaborative transcription factor networks are promoted by OCT4 in the progression of prostate cancer . Nat Com‑ mun . 2021 ; 12 : 3766 . 206 . Zhang Z , Boskovic Z , Hussain MM , Hu W , Inouye C , Kim HJ , Abole AK , Doud MK , Lewis TA , Koehler AN , Schreiber SL , Tjian R . Chemical pertur‑ bation of an intrinsically disordered region of TFIID distinguishes two modes of transcription initiation . Elife . 2015 ; 4 : e07777 . 207 . Rangel LP , Ferretti GDS , Costa CL , Andrade S , Carvalho RS , Costa DCF , Silva JL . p53 reactivation with induction of massive apoptosis‑1 ( PRIMA‑ 1 ) inhibits amyloid aggregation of mutant p53 in cancer cells . J Biol Chem . 2019 ; 294 : 3670 – 82 . 208 . Wang C , Lu H , Liu X , Gao X , Tian W , Chen H , Xue Y , Zhou Q . A natural product targets BRD4 to inhibit phase separation and gene transcrip‑ tion . iScience . 2022 ; 25 : 103719 . 209 . Babinchak WM , Dumm BK , Venus S , Boyko S , Putnam AA , Jankowsky E , Surewicz WK . Small molecules as potent biphasic modulators of protein liquid‑liquid phase separation . Nat Commun . 2020 ; 11 : 5574 . 210 . Liu J , Xie Y , Guo J , Li X , Wang J , Jiang H , Peng Z , Wang J , Wang S , Li Q , Ye L , Zhong Y , Zhang Q , Liu X , Lonard DM , Wang J , O’Malley BW , Liu Z . Targeting NSD2‑mediated SRC‑3 liquid‑liquid phase separation sensitizes bortezomib treatment in multiple myeloma . Nat Commun . 2021 ; 12 : 1022 . 211 . Singatulina AS , Hamon L , Sukhanova MV , Desforges B , Joshi V , Bouhss A , Lavrik OI , Pastré D . PARP‑1 activation directs FUS to DNA damage sites to form PARG‑reversible compartments enriched in damaged DNA . Cell Rep . 2019 ; 27 : 1809‑1821 . e1805 . 212 . Lu B , Zou C , Yang M , He Y , He J , Zhang C , Chen S , Yu J , Liu KY , Cao Q , Zhao W . Pharmacological inhibition of core regulatory circuitry liquid‑ liquid phase separation suppresses metastasis and chemoresistance in osteosarcoma . Adv Sci ( Weinh ) . 2021 ; 8 : e2101895 . 213 . Wippich F , Bodenmiller B , Trajkovska MG , Wanka S , Aebersold R , Pelk‑ mans L . Dual specificity kinase DYRK3 couples stress granule condensa‑ tion / dissolution to mTORC1 signaling . Cell . 2013 ; 152 : 791 – 805 . 214 . Bhagwat AS , Roe JS , Mok BYL , Hohmann AF , Shi J , Vakoc CR . BET bromodomain inhibition releases the mediator complex from select cis‑regulatory elements . Cell Rep . 2016 ; 15 : 519 – 30 . 215 . Gilan O , Lam EY , Becher I , Lugo D , Cannizzaro E , Joberty G , Ward A , Wiese M , Fong CY , Ftouni S , Tyler D , Stanley K , MacPherson L , Weng CF , Chan YC , Ghisi M , Smil D , Carpenter C , Brown P , Garton N , Blewitt ME , Bannister AJ , Kouzarides T , Huntly BJ , Johnstone RW , Drewes G , Dawson SJ , Arrowsmith CH , Grandi P , Prinjha RK , Dawson MA . Functional interde‑ pendence of BRD4 and DOT1L in MLL leukemia . Nat Struct Mol Biol . 2016 ; 23 : 673 – 81 . 216 . Nilson KA , Guo J , Turek ME , Brogie JE , Delaney E , Luse DS , Price DH . THZ1 Reveals roles for Cdk7 in Co‑transcriptional capping and pausing . Mol Cell . 2015 ; 59 : 576 – 87 . 217 . Zhang T , Kwiatkowski N , Olson CM , Dixon‑Clarke SE , Abraham BJ , Greifenberg AK , Ficarro SB , Elkins JM , Liang Y , Hannett NM , Manz T , Hao M , Bartkowiak B , Greenleaf AL , Marto JA , Geyer M , Bullock AN , Young RA , Gray NS . Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors . Nat Chem Biol . 2016 ; 12 : 876 – 84 . 218 . Wheeler RJ . Therapeutics‑how to treat phase separation‑associated diseases , Emerg Top . Life Sci . 2020 ; 4 : 307 – 18 . 219 . Luo YY , Wu JJ , Li YM . Regulation of liquid‑liquid phase separation with focus on post‑translational modifications . Chem Commun ( Camb ) . 2021 ; 57 : 13275 – 87 . 220 . Chong PA , Vernon RM , Forman‑Kay JD . RGG / RG Motif regions in RNA binding and phase separation . J Mol Biol . 2018 ; 430 : 4650 – 65 . 221 . Dao TP , Kolaitis RM , Kim HJ , O’Donovan K , Martyniak B , Colicino E , Hehnly H , Taylor JP , Castañeda CA . Ubiquitin modulates liquid‑liquid phase separation of UBQLN2 via disruption of multivalent interactions . Mol Cell . 2018 ; 69 : 965‑978 . e966 . 222 . de Thé H , Pandolfi PP , Chen Z . Acute promyelocytic leukemia : a para‑ digm for oncoprotein‑targeted cure . Cancer Cell . 2017 ; 32 : 552 – 60 . 223 . Sun Y , Lau SY , Lim ZW , Chang SC , Ghadessy F , Partridge A , Miserez A . Phase‑separating peptides for direct cytosolic delivery and redox‑activated release of macromolecular therapeutics . Nat Chem . 2022 ; 14 : 274 – 83 . 224 . Guo RC , Zhang XH , Fan PS , Song BL , Li ZX , Duan ZY , Qiao ZY , Wang H . In vivo self‑assembly induced cell membrane phase separation for improved peptide drug internalization . Angew Chem Int Ed Engl . 2021 ; 60 : 25128 – 34 . Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in pub‑ lished maps and institutional affiliations .